Indicia informative of characteristics of insertable medical devices

Information

  • Patent Grant
  • 9265912
  • Patent Number
    9,265,912
  • Date Filed
    Wednesday, March 13, 2013
    12 years ago
  • Date Issued
    Tuesday, February 23, 2016
    9 years ago
Abstract
A system by which resource information relating to an insertable medical device, such as an intravascular catheter, can be identified by its source so as to be accessed by a practitioner, caregiver, or patient, is disclosed. In particular, a resource information key is included at a predetermined key location on or proximate to the medical device, wherein the key indicates the source of the resource information. In one example embodiment, therefore, an insertable medical device for establishing intravascular access to a patient, such as a peripherally inserted central catheter (“PICC”), is disclosed and comprises: an internal portion, and a portion external to the patient that includes a resource information key indicating a website where a user can acquire resource information relating to the medical device. In other embodiments indicia are provided as quick response (“QR”) codes, and as various markings to indicate compatibility of the medical device with ethanol.
Description
BRIEF SUMMARY

Manufacturers of medical devices, including those configured for insertion into the body of a patient, generally make every effort to ensure that each device is accompanied by a comprehensive collection of printed and other material intended to ensure that the device is placed and used correctly. Examples of such devices include peripherally inserted central catheters (“PICCs”), dialysis catheters, peripheral catheters, central venous catheters (“CVCs”), access ports, and other devices designed to provide vascular access to the patient.


Despite the above-mentioned efforts, however, situations may arise where further information regarding a particular medical device is desired or needed in order for the device to be properly employed. For instance, the accompanying medical device documentation may be misplaced or lost, or further information may be released after the device was manufactured and distributed. Such information may be needed by the practitioner placing the medical device in the patient, or by the patient or caregiver after device insertion. In these or other cases, it may be difficult for the practitioner, patient, or caregiver to readily acquire needed information relating to the device.


In light of the above discussion, therefore, a need exists for a solution that overcomes the above-identified challenges relating to the availability of medical device information for insertable medical devices.


Embodiments of the present invention have been developed in response to the above and other needs in the art. Briefly summarized, these embodiments are directed to a system by which resource information relating to an insertable medical device, such as an intravascular catheter, can be identified by its source so as to be accessed by a practitioner, caregiver, or patient. In particular, a resource information key is included at a predetermined key location on or proximate to the medical device, wherein the key indicates the source of the resource information.


In one example embodiment, therefore, an insertable medical device for establishing intravascular access to a patient, such as a peripherally inserted central catheter (“PICC”), is disclosed and comprises: an internal portion configured for intravascular insertion into the patient, and a portion external to the patient. The exterior portion of the PICC includes a resource information key that is positioned at a predetermined key location. The resource information key indicates a website where a user can acquire the resource information relating to the medical device.


In other embodiments, an insertable medical device includes a two-dimensional code, such as a quick response (“QR”) code that is electronically readable so as to provide information regarding a characteristic or other aspect of the medical device to a user or other person. In yet other embodiments, various indicia are disclosed for indicating to a user a particular characteristic of the medical device, such as its compatibility with respect to ethanol and other alcohol-based fluids.


These and other features of embodiments of the present invention will become more fully apparent from the following description and appended claims, or may be learned by the practice of the invention as set forth hereinafter.





BRIEF DESCRIPTION OF THE DRAWINGS

To further clarify the above and other advantages and features of the present invention, a more particular description of the invention will be rendered by reference to specific embodiments thereof that are illustrated in the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope. The invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:



FIG. 1 is a top view of a peripherally inserted central catheter (“PICC”) partially inserted in the arm of a patient, thereby depicting one example of an insertable medical device that benefits from the present invention according to one embodiment thereof;



FIG. 2 is a perspective view of the PICC of FIG. 1 before insertion into a patient, including a resource information key according to one embodiment;



FIG. 3 is a close-up top view of a portion of the PICC of FIG. 2, showing further details of the resource information key;



FIG. 4 is a top view of a connector portion of the PICC of FIG. 2, showing a resource information key location according to one embodiment;



FIG. 5 is a top view of a clamp portion of the PICC of FIG. 2, showing a resource information key location according to one embodiment;



FIG. 6 is a top view of a bifurcation hub portion of the PICC of FIG. 2, showing a resource information key location according to one embodiment;



FIG. 7 is a top view of a catheter portion of the PICC of FIG. 2, showing a resource information key location according to one embodiment;



FIG. 8 is a top view of a portion of the PICC of FIG. 2, including a hang tag having a resource information key location according to one embodiment;



FIG. 9 is a perspective view of a PICC coupled with a stabilization device having a plurality of resource information key locations according to one embodiment;



FIG. 10 is a top view of a PICC and stabilization device together with a dressing having a plurality of resource information key locations according to one embodiment of the present invention;



FIG. 11 is a perspective view of a dual septum implantable access port, depicting an example of an implantable medical device that benefits from the present invention according to one embodiment thereof;



FIG. 12 is a bottom view of the dual septum implantable access port of FIG. 11, including a reversed radiopaque resource information key according to one embodiment of the present invention;



FIG. 13A is a perspective view of a catheter assembly including a coded indicium according to one embodiment;



FIG. 13B shows a sample QR code as a coded indicium according to one embodiment;



FIG. 14 is a top view of the bifurcation of the catheter assembly of FIG. 13A, showing the coded indicium;



FIG. 15 is a perspective view of an access port including a coded indicium according to one embodiment;



FIG. 16 is a top view of an access port including a coded indicium included on a septum thereof according to one embodiment;



FIG. 17 is a perspective view of a portion of a catheter assembly including certain indicia according to one embodiment;



FIG. 18 is a perspective view of a portion of a catheter assembly including certain indicia according to one embodiment;



FIG. 19 is a perspective view of a portion of a catheter assembly including certain indicia according to one embodiment;



FIG. 20 is a perspective view of a portion of a catheter assembly including certain indicia according to one embodiment;



FIG. 21 is a perspective view of a portion of a catheter assembly including certain indicia according to one embodiment;



FIG. 22 is a perspective view of a portion of a catheter assembly including certain indicia according to one embodiment;



FIG. 23 is a perspective view of a portion of a catheter assembly including certain indicia according to one embodiment;



FIG. 24 is a perspective view of a portion of a catheter assembly including certain indicia according to one embodiment;



FIG. 25 is a perspective view of a portion of a catheter assembly including certain indicia according to one embodiment;



FIG. 26 is a perspective view of a portion of a catheter assembly including certain indicia according to one embodiment;



FIG. 27 shows various symbols that may serve as indicia according to one embodiment; and



FIG. 28 is a bottom view of a radiopaque insert for use with an implantable port and including certain indicia according to one embodiment.





DETAILED DESCRIPTION OF SELECTED EMBODIMENTS

Reference will now be made to figures wherein like structures will be provided with like reference designations. It is understood that the drawings are diagrammatic and schematic representations of exemplary embodiments of the invention, and are not limiting of the present invention nor are they necessarily drawn to scale.


I. Resource Information Key


FIGS. 1-10 depict various features of embodiments of the present invention, which is generally directed to a system by which resource information relating to an insertable medical device, such as an intravascular catheter device, can be identified so as to be accessed by a practitioner, caregiver, or patient.


Reference is first made to FIG. 1, which depicts a medical device, generally designated at 10, that is configured for insertion into a body 12 of a patient. In particular, the medical device 10 depicted in FIG. 1 is a dual lumen peripherally inserted central catheter (“PICC”), and is shown inserted in the arm of the patient body 12. Also shown in FIG. 1 is a resource information key location, to be described more fully below, generally indicated at 50.


It should be noted that, though the accompanying drawings depict a PICC device, other medical devices that are at least partially inserted into the patient can also benefit from the principles of the present invention to be described herein. Examples of such devices include dialysis catheters, peripheral catheters, cannulas, infusion sets, and other devices designed to enable intravascular access to the patient. In yet other embodiments, completely implantable devices, such as subcutaneous access ports, can also employ embodiments of the present invention. As such, the breadth of the present invention should not be construed as being limited to the medical devices explicitly depicted and described herein.


Reference is now made to FIG. 2, depicting in further detail the PICC shown in FIG. 1 before placement in a patient, here shown at 20. Comparison of FIG. 2 with FIG. 1 will reveal that the PICC 20 includes an internal portion 20A for insertion into the vasculature of a patient and an external portion 20B that remains outside of the body of the patient during PICC use. As embodiments of the present invention can be applied to other insertable medical devices, the internal and external portions of other devices would be varied according to the particular design of the insertable medical device. As shown, the PICC 20 generally includes a catheter 22, an extension leg assembly 24, and a bifurcation hub 26 that operably interconnects the catheter to the extension leg assembly.


In further detail, the extension leg assembly 24 is configured to enable the infusion or aspiration of fluids to or from the patient vasculature via the catheter 22 and bifurcation hub 26. The extension leg assembly 24 includes a first connector 30 and second connector 32 that are connected to a first extension tube 40 and a second extension tube 42, respectively. A first clamp 44 is included on the first extension tube 40, and a second clamp 46 is included on the second extension tube 42. Note that more or fewer extension tubes could be included with the PICC 20.


In accordance with one embodiment, a key is provided with the PICC 20 to enable further information relating to the PICC to be accessed by a patient, practitioner, caregiver, etc. Specifically, a resource information key location (“RIKL”), generally indicated at 50, is provided on the PICC 20. The RIKL 50 defines an area of the PICC 20 where a resource information key 52 is located. As will be described, the resource information key 52 provides data to one as to a source where further information regarding the PICC 20 can be accessed. Not providing the information itself, it instead acts as a “key,” enabling further PICC-related information to be located.


The contents of the resource information key 52 can be any alpha-numeric, typographical, graphical content or other visual indicia that can visually convey to the user the source where further information regarding the medical device can be found. As such, letters, numbers, graphical or other symbols, etc. may be used alone or in combination to form the resource information key 52. In yet another embodiment, the key could be identified not visually, but rather by palpation.


For example, and as shown in greater detail in FIG. 3, the resource information key 52 in one embodiment is implemented as a website uniform resource locator (“URL”), www.powerpicc.com, where a user can access via the Internet various web pages giving further information regarding the structure, use, precautions, or other aspects relating to the PICC 20. Such information may be beneficial to the user, or may be critical in order to ensure patient safety, especially in instances where printed material that originally accompanied the PICC 20 has been misplaced or lost, or when new information has become available regarding the PICC.


In light of the above discussion, it is appreciated that in accordance with embodiments of the present invention the resource information key 52 can take one of several forms, especially with regard to pointing the user to an Internet-based resource. As such, examples of a resource information key include a web address, URL, URI, IP address, etc., which in turn direct the user to a location on the Internet where the further information may be found. Of course, the content of the resource information key 52 can be varied according to the device on which it is found.


As shown in FIGS. 2 and 3, the resource information key 52 is included in the RIKL 50, which in turn is disposed on a portion of the second extension tube 42. Generally, the RIKL 50 is chosen so as to be easily viewable by the user. The RIKL 50 should also be sized large enough for the resource information key 52 to be read without undue effort. Generally, locations proximally disposed on the external portion of the medical device are advantageous so as to enable the key to be readily viewed. However, as will be seen in the additional example embodiments to be discussed below, the key may be located at a variety of locations on the medical device. The resource information key 52 can be defined on the RIKL 50 in a variety of ways, including etching, embossing, labeling, ink or other printing, etc.


As mentioned, though it is located on the second extension tube 42 in the embodiments shown in FIGS. 1-3, the resource location key in other embodiments can be positioned at other resource information key locations on the PICC or other insertable medical device. FIGS. 4-8 give various examples of such alternative placement locations for the resource information key. In FIG. 4, for example, the RIKL 50 is disposed on the first connector 30 of the extension leg assembly 24, while FIG. 5 shows the RIKL disposed on a cap 56 affixed to the first clamp 44.


In FIG. 6, the RIKL 50 is disposed on an axial portion of the bifurcation hub 26. Alternatively, the RIKL can be disposed on one or both of two suture wings 60 extending from the body of the bifurcation hub 26. In FIG. 7, the RIKL 50 is disposed on a proximal portion 22A of the catheter 22 that is not inserted into the patient. In FIG. 8, a hang tag 80 or other attachable component can be added to the PICC 20 to include the RIKL 50 thereon.


The embodiments shown in FIGS. 1-8 depict the RIKL 50 disposed on a portion of the PICC 20 itself. However, the RIKL may also be positioned on a component that is not part of, but typically used in conjunction with, the PICC 20 or other insertable medical device. In FIG. 9, for example, a catheter stabilization device sold under the trademark STATLOCK® is shown at 90 and is commonly used to assist in securing the PICC 20 in place after insertion into the patient vasculature. The stabilization device 90 includes a base 92 and a retention assembly 94 for retaining the bifurcation hub 26 of the PICC 20. The retention assembly 94 includes selectively closeable lids 96. FIG. 9 further shows two possible areas for the RIKL 50: on a portion of the device base 92, and on one or both of the lids 96. Other areas could, of course, be employed on the stabilization device 90 for positioning the RIKL 50.



FIG. 10 shows an adhesive dressing 100 that is commonly used to cover a portion of the PICC 20 and stabilization device 90 for increased hygiene. The dressing 100 here includes two RIKLs 50 as yet another example of possible locations for placement of the resource information key. It is appreciated that, in addition to the examples discussed above, many other key locations could be devised on a variety of insertable medical devices, including devices that are fully implanted in the patient body, such as access ports, if desired. The present invention should not therefore be limited to only what is explicitly shown and described herein.



FIGS. 11 and 12 depict the present invention as employed in yet another example embodiment. In particular, FIGS. 11 and 12 depict a dual-septum access port 110 configured for subcutaneous implantation into the body of a patient. The access port 110 includes a first septum 112 covering a first reservoir, and a second septum 114 covering a second reservoir. The reservoirs are defined by a body 116. The resource information key 52 is disposed at a predetermined resource information key location 50 on a bottom surface 118 of the access port body 116.


The key 52 in FIG. 12, “www.bardpp.com,” is positioned on the bottom surface 118 in an inverse, or mirror-image, configuration. Further, the material used to define the key 52 includes a radiopaque material such that the key 52 is visible when a radiographic, or x-ray, image is taken of the implanted access port 110. The inverse key 52 in this case will appear non-inverse when the x-ray image is viewed, allowing the orientation of the implanted access port to be readily ascertained. Of course, the key may be positioned in any one of a variety of configurations, inverse or not, and locations on the access port.


The content of the key 52 can also serve to identify the access port 110 in terms of type, size, manufacturer, etc., if desired. In addition, the key 52 provides a source to which an observer can go to access further information regarding the access port 110, as in previous embodiments. Note that, while shown here in connection with a dual-septum access port, single-septum or otherwise configured access ports, as well as other types of implantable medical devices, can also benefit from the principles described herein with regard to the present embodiment.


II. Coded and Ethanol-Related Indicia

Reference is now made to FIGS. 13A-14 in describing details of identifying indicia for a medical device according to one embodiment. As shown, FIG. 13A depicts a medical device, namely a catheter 120, generally including a distal portion 120A and a proximal portion 120B. In detail, the catheter 120 includes a catheter tube 222 defining one or more lumens. The catheter tube 222 defines two lumens, though the number of lumens can vary. Each of two extension legs 224 of the catheter 120 is in fluid communication with a respective one of the lumens of the catheter tube 222. A bifurcation 226 fluidly connects the lumens of the catheter tube 222 with the extension legs 224. Luer connectors 228 are disposed on proximal ends of the extension legs 224. Also, clamps 230 are disposed on the extension legs 224 to enable selective occlusion thereof.


In accordance with the present embodiment, a coded indicium 240 is included with the medical device shown here, i.e., the catheter 120. The coded indicium 240 is configured to provide information relating to a characteristic, property, and/or quality of the catheter 120 or other medical device with which it is associated. For instance, the coded indicium 240 can be utilized to access an Internet webpage or online resource, with a suitable Internet or web browser such as those found on smart phones, laptop computers, Internet-connected devices, etc., so as to enable a user to acquire further information regarding the catheter 120.


Examples of resources to which the coded indicium 240 can direct a user include: an Internet webpage giving further details and/or instructions regarding the medical device; visual and/or multimedia information, including videos that described and or demonstrate use of the medical device; instructional websites that direct a user how to insert, remove, and/or use the medical device; identification information regarding the medical device including type, size, manufacturer, etc.; warnings or official information promulgated by the manufacturer or an official or regulatory body; recently released or published information regarding the medical device, etc. These and other resources and information can be the targets to which a user is directed by the coded indicium 240.


In the present embodiment, the coded indicium 240 is implemented as a two-dimensional coded symbol, such as a quick response (“QR”) code 242. Specifically, and as shown in FIGS. 13A and 14, the QR code 242 is a two-dimensional matrix barcode and is included on a top portion of the bifurcation 226, a part of the proximal portion 120B of the catheter 120. A relatively larger view of the QR code 242 is shown in FIG. 13B. Note that the QR code 242 can be included at a suitable location on the catheter 120 in addition to what is shown in FIG. 13A, including placement of any of the components shown in FIG. 13A. The QR code 242 can be added to the catheter 120 using any acceptable process, including printing, adhesive sticker, etching or engraving, insert molding, etc. In addition, the QR code 242 can be included on suitable medical devices so as to be radioopaque, enabling identification of the medical device via x-ray imaging technology. Also, other two-dimensional coded symbols in addition to QR codes can be included on the medical device to serve as a coded indicium, as appreciated by one skilled in the art. Similarly, the size and particular configuration of the QR code can vary from what is shown here.


The QR code 242 is encoded so as to be electronically scannable—also referred to herein as machine readable or optically scannable—such that a device configured to scan and interpret QR codes can visually read the QR code and access the resource or information associated therewith for presentation to the user. One example of such a device is a smartphone with a camera that can take a picture of or otherwise electronically scan (such as via an optical scan) the QR code 242, then access the Internet or other portal so as to retrieve the resource or information with which the QR code is associated before presenting the resource or information to a user, such as on a display of the smartphone. Smartphones and other electronic devices commonly include, or can be modified to include, suitable software or applications that enable QR codes and other scannable codes to be imaged and interpreted. In another embodiment, a portable computer or special-purpose computing device can be used to scan, interpret, and access the resource or information associated with the QR code.


As an example of the above, the catheter 120 including the coded indicium 240 as seen in FIG. 13A can be inserted into a patient in order to establish vascular access. Before or after insertion of the catheter 120, a user can electronically scan the QR code 242 with a smartphone or other suitable scanning device including the appropriate software or application. Once the QR code 242 has been scanned, the software/application can convert the code to a uniform resource locator (“URL”) and direct a web browser on the smartphone to access a website or other Internet location and retrieve the resource and/or information associated with the QR code. The resource/information can include instructions for flushing the catheter 120, for instance. The resource and/or information will be displayed on the smartphone display, enabling the user to read and use information.


As mentioned, various other types of devices can be employed to scan, interpret, and present the QR code-associated information to the user. Also, in addition to remotely accessing information via the Internet or other source, other avenues for acquiring the information associated with the QR code can be employed, including accessing the information locally located on the smartphone or other scanning device itself.



FIGS. 15 and 16 show placement of the QR code 242 in accordance with other embodiments. In FIG. 15, an access port 260 is shown, including a body 262 and attached septum 264. A stem 266 extends from the port body 262. The QR code 242 is shown in this embodiment located on a lateral side of the port body 262, where it may be scanned prior to placement of the access port 260 into the body of a patient to access the corresponding information. In FIG. 16, the QR code 242 is positioned on the septum 264. In one embodiment, the QR code 242 of FIG. 16 can be configured to be radiopaque so as to enable identification of the access port 260 via the QR code 242 after the port has been subcutaneously implanted within the body of a patient. Thus, it is appreciated that use of the QR code to facilitate the acquisition of further resources/information regarding one of a variety of medical devices is contemplated.


Reference is now made to FIG. 17 in describing a medical device according to another embodiment. In particular, FIG. 17 shows a catheter 320 including an elongate catheter tube 322 defining two lumens, though other lumen configurations are also possible. A proximal end of the catheter tube 322 is operably attached to a bifurcation 326. A proximal end of the bifurcation 326 is operably attached to two extension legs 324, each defining a lumen such that a fluid path is defined between each extension leg and a corresponding lumen of the catheter tube 322. More or fewer extension legs can be included according to catheter design. Each extension leg 324 includes a corresponding luer connector 328. A clamp 330 is also optionally included on each extension leg 324.


In accordance with the present embodiment, various indicia are included with the catheter assembly or other medical device to an observer a predetermined characteristic, quality, property, or other aspect of the catheter assembly. In the embodiments described hereinbelow, the predetermined characteristic includes compatibility of the catheter with alcohol-based solutions such as ethanol, e.g., the ability of ethanol to be disposed within the catheter or extension leg lumens for a period of time so as to “lock” (also referred to herein as “ethanol lock”) the catheter and prevent clotting, sheath formation, and/or occlusion in or near the tip of the catheter. The use of ethanol to lock the lumen(s) of a catheter lumen is also useful for catheter infection prevention and treatment. “Ethanol compatibility” and “ethanol locking” are both used herein to indicate the ability of the catheter or other medical device to withstand the effects of such contact with ethanol (or other alcohol-based fluids, in one embodiment) without unacceptably degrading the catheter/device. In addition to indicating ethanol compatibility, the indicia to be described hereinbelow can indicate other characteristics, qualities, or properties of the catheter or medical device. Thus, the discussion to follow should not be considered limiting in any way.


In light of the above, FIG. 17 shows an ethanol lock indicium (“indicium” or “indicia”) 340, according to one embodiment, for indicating ethanol compatibility of the catheter 10, including the ability of the catheter to be locked with a solution containing liquid ethanol. As shown, the indicium 340 in the present embodiment is implemented as an indicator color 342A applied to the bifurcation 326 of the catheter 320 in combination with an alphanumeric marking 342B included on the clamps 330 of the extension leg 324,


In greater detail, the indicator color 342A of the bifurcation indicates to an observer in the present embodiment that the catheter assembly can be locked with ethanol. Such indication is important, as not all catheter assemblies are suitable for or can suitably withstand the presence of ethanol. In the present embodiment, the indicator color 342A disposed on the bifurcation 326 is yellow, though other colors may also be used to indicate this or another catheter/medical device characteristic, quality, or property. In addition, in the present embodiment the clamps 330 are also colored yellow to further indicate ethanol compatibility. More, fewer, or other components of the catheter or suitable medical device may be colored with a predetermined color to indicate the characteristic, quality, or property of the device.


The alphanumeric marking 342B mentioned above serves in the present embodiment as an additional component of the indicium 340, in combination with the bifurcation indicator color 342A. As shown in FIG. 17, the alphanumeric marking 342B is disposed on each of the clamps 330 and includes an alphanumeric message, namely, “EtOH,” a shorthand designation for ethanol. This indicates to an observer the compatibility of the catheter 320 with ethanol.


In one embodiment, one or more of the catheter tube 322, bifurcation 326, and extension legs 324 include an ethanol-resistant material, such as an aromatic polycarbonate polyurethane that is also rated to withstand typical power injection pressures of about 190 psi. Other suitable plastics can also be employed, including aromatic polyether, aliphatic polycarbonate, and aliphatic polyether polyurethanes. In one embodiment, an ethanol solution of about 70% concentration is employed in locking the catheter 320, though other concentrations and formulations can be employed and indicated by the indicium.


It is appreciated that the indicator color and alphanumeric marking that are included in the ethanol lock indicium of the present embodiment may be used together or separately, placed on differing parts or components of the catheter or medical device, and may be configured differently, as discussed further below. Also as mentioned, the indicium may be used to indicate other characteristics, qualities, and/or properties of the catheter or medical device. In the case of catheters, though the present figures show a PICC catheter, other catheter types can benefit from the present disclosure, including CVCs, tunneled and non-tunneled dialysis catheters, peripheral IV catheters, etc. Further, the size and length, etc., can vary from what is shown and described.



FIG. 18 shows another example of an ethanol lock indicium 340 according to one embodiment, wherein the indicium is implemented as an iconic marking 352 placed on each of the clamps 330 of the extension legs 324. In the present embodiment, the iconic marking 352 includes an image of a padlock with a letter “e” superimposed on the padlock image. The clamps 330 can optionally be colored to further indicate, as does the iconic marking 352, compatibility of the catheter with ethanol for purposes of ethanol locking, for instance and as described above. The iconic marking 352 is printed on each of the clamps 330 in the present embodiment, though other methods for placing the marking on the clamps can be employed including placement of indicia on only one extension leg to indicate ethanol compatibility for that leg and corresponding catheter lumen only.


Note that the position, design, size, content, meaning, etc. of the iconic marking can be varied from what is shown and described here. As an example of this, FIG. 19 shows the ethanol lock indicium 340 implemented as a mixed marking 362 disposed on the clamps 330. The mixed marking 362 includes both an iconic marking and an alphanumeric marking. In detail, the iconic portion of the mixed marking 362 includes the letter “e” superimposed atop an image of a padlock, as in FIG. 18. The alphanumeric portion of the mixed marking 362 includes the shorthand designation “EtOH,” similar to the embodiment of FIG. 17. This and other possible combinations of indicia are therefore contemplated.



FIG. 20 shows another example of an ethanol lock indicium 340 according to one embodiment, wherein the indicium is implemented as an alphanumeric marking 372 placed on each of the luer connectors 328 of the extension legs 324. In the present embodiment, the letters “EtOH” are printed to indicate ethanol locking capability, though other letters, words, symbols, numbers, etc., could be used to indicate ethanol compatibility or another characteristic, quality, and/or property of the medical device.



FIG. 21 shows another example of an ethanol lock indicium 340, wherein the indicium is implemented as an alphanumeric marking 382 disposed on the tube of each extension leg 324. In the present embodiment, the words “ethanol lockable” are printed to indicate ethanol locking capability, though other combinations of letters, words, symbols, numbers, colors, etc., could be used, as before.



FIG. 22 shows another example of an ethanol lock indicium 340 according to one embodiment, wherein the indicium is implemented in combination as an indicator piece 392A that is attached to or otherwise included with the catheter assembly 10, together with an alphanumeric or other suitable marking 392B included on the indicator piece. In the illustrated embodiment, the indicator piece 392A is shaped as a mini padlock indicating that the catheter assembly 10 is ethanol lockable. In addition, the alphanumeric marking 392B including an “e,” indicating ethanol lockability, is printed on the padlock-shaped indicator piece 392A. Thus it is seen that, as in this and other embodiments, multiple modes of indication, e.g., color, alphanumeric, iconic, symbolic, and shaped indicators, can be employed to convey to an observer the predetermined characteristic, quality, and/or property of the catheter or medical device. In one embodiment, all or a portion of the indicator piece can be colored, such as in yellow, for instance. Or in another embodiment, the indicator piece includes no alphanumeric or iconic marking.


Note that each of the two padlock-shaped indicator pieces 392A is slidably disposed about a corresponding one of the tubes of the extension legs 324. Though they can be fixably or movably included on other portions of the catheter assembly, it is appreciated that in one embodiment the indicator pieces 392A are such that they do not interfere with either use of the device or patient comfort or safety. Note that the size, shape, color, number, location, and design of the indicator piece(s) can vary from what is shown and described here.



FIG. 23 shows another example of an ethanol lock indicium 340 according to one embodiment, wherein the indicium is implemented in combination as an indicator piece 402A, together with an alphanumeric or other suitable marking 402B included on the indicator piece. In the illustrated embodiment, the indicator piece 402A is cylindrically shaped and hollow so as to slidably fit over one of the tubes of the extension legs 324 of the catheter 320. In addition, the alphanumeric marking 402B including the letters “EtOH,” indicating ethanol lockability, is printed on the cylindrical indicator piece 402A.



FIG. 24 shows another example of an ethanol lock indicium 340 according to one embodiment, wherein the indicium is implemented in combination as an indicator color marking 412A covering about half of each of two valved connectors 408 disposed at the ends of the extension legs 324, together with an alphanumeric marking 412B placed on each of the valved connectors atop the indicator color markings 412A. In the illustrated embodiment, the indicator color marking 412A covering half of each valved connector 408 is yellow, though other colors and the coloring of additional or alternative catheter components is possible. Note that the bifurcation is also colored yellow to serve, as in previous embodiments, as a further component of the indicium 340 to indicate ethanol compatibility. In addition, the alphanumeric marking 412B including the letters “EtOH,” also indicating ethanol lockability, is printed on the cylindrical indicator piece 402A.



FIG. 25 shows another example of an ethanol lock indicium 340 according to one embodiment, wherein the indicium is implemented as a mixed alphanumeric/iconic marking 422 placed on each of the valved connectors 408, as shown. In the illustrated embodiment, the mixed marking 422 includes the letters “EtOH,” together with an iconic padlock image including the letter “e” superimposed thereon, both indicating ethanol lockability. In contrast, FIG. 26 shows the ethanol lock indicium 340 as including only an iconic marking 432 of a padlock image including the letter “e” superimposed thereon to indicate ethanol lockability, according to yet another embodiment.



FIG. 27 shows various examples of possible ethanol locking indicia 340 according to one embodiment, including: a padlock icon with the letters “EtOH” superimposed thereon (442A); a padlock icon with a percentage concentration of ethanol to be used with the medical device (442B); a colored padlock icon, marked in the color orange here (442C); a padlock icon including a keyhole (442D); a rounded padlock icon (442E); a padlock icon including a lowercase letter “e” superimposed thereon (442F); and a padlock icon including an uppercase letter “E” superimposed thereon (442G). Note these and the other markings and indicia discussed herein can be included with the catheter or medical device in any one of a variety of ways including an adhesive or other decal or skin, ink-printed, a physical piece, etc., and can be applied to any suitable portion of the device or component closely associated therewith via any suitable method, including direct surface application, pad printing, embossing, insert molding, over molding, etc.



FIG. 28 shows another example of an ethanol lock indicium 340 according to one embodiment, wherein the indicium is implemented as an iconic marking 452 that includes a padlock image including the letter “e” superimposed thereon to indicate ethanol lockability. In the present embodiment, the marking 452 is defined in a body 448 of a radiopaque insert 446 that is in turn included with an implantable access port. In one embodiment the insert 446 is relatively thin and sheet-like and includes a mixture of acetyl resin and bismuth trioxide, though many other suitable materials can be used to define the insert. The marking 452 in the present embodiment is defined as a cut-out through the sheet-like insert body 448 such that it provides a contrast to the insert body when viewed via x-ray imaging technology after the access port has been implanted into the body of the patient. Also optionally included on the insert 446 is a power injection indicium 450, indicating suitability of the port for power injection of contrast media or other fluids therethrough. Further details regarding the radiopaque insert and associated access port can be found in U.S. Pat. No. 8,029,482, filed Jun. 8, 2010, and entitled “Systems and Methods for Radiographically Identifying an Access Port,” which is incorporated herein by reference in its entirety. Note that the size, shape, and configuration of the insert can vary from what is shown and described herein. Note also that the type, size, configuration, purpose etc., of the ethanol lock indicium can also vary.


In light of the above, in one embodiment it is appreciated that the indicia discussed herein can be included with a component that is employed or associated with the medical device rather than applied to the medical device itself. This includes inclusion of the indicia on a luer cap or needle-less injection cap, for instance, each of which operably connects to the luer connectors of the catheter. As such, any one or more of the indicia spoken above can be associated with such caps or other components employed with the catheter or other medical device. In one embodiment, it is further appreciated that the indicia can be formed so as to be radiopaque, thus enabling detection via x-ray imaging technology.


It is appreciated that, in light of the above, the indicia described herein can be implemented in other ways, for other purposes than indicating ethanol locking capability, and for other devices in addition to catheter assemblies. The above embodiments should therefore not be considered limiting in any way.


The present invention may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative, not restrictive. The scope of the invention is, therefore, indicated by the appended claims rather than by the foregoing description. All changes that come within the meaning and range of equivalency of the claims are to be embraced within their scope.

Claims
  • 1. A medical device for at least partial insertion into a patient, the medical device comprising: a peripherally-inserted central catheter;a device body; andat least one ethanol indicium included with the device body, the at least one ethanol indicium perceptible by an observer to indicate a compatibility of the medical device with ethanol or other alcohol-based substance, wherein the at least one ethanol indicium includes at least one of an iconic marking including a symbol indicative of a lock and an alphanumeric marking indicative of the word “ethanol”.
  • 2. The medical device as defined in claim 1, wherein the at least one ethanol indicium is visually perceptible by the observer.
  • 3. The medical device as defined in claim 1, wherein the medical device includes the catheter defining at least one lumen and wherein compatibility of the catheter indicates that ethanol can be disposed within the at least one lumen of the catheter without compromise to the functionality of the catheter.
  • 4. The medical device as defined in claim 3, wherein the at least one ethanol indicium includes a coloring included on a bifurcation.
  • 5. The medical device as defined in claim 4, wherein the coloring is substantially yellow and wherein the coloring is further included on at least one additional component of the catheter.
  • 6. The medical device as defined in claim 1, wherein the iconic marking includes a padlock image.
  • 7. The medical device as defined in claim 1, wherein the at least one ethanol indicium includes shorthand indication for the word “ethanol”.
  • 8. The medical device as defined in claim 1, wherein the at least one ethanol indicium includes a discrete indicator piece that is slidably attached to a portion of the catheter.
  • 9. The medical device as defined in claim 8, wherein the discrete indicator piece is slidably attached to an extension leg of the catheter.
  • 10. The medical device as defined in claim 9, wherein the discrete indicator piece is one of a cylindrical shape and a padlock shape.
  • 11. The medical device as defined in claim 1, wherein the at least one ethanol indicium is disposed on a luer connector of the catheter.
  • 12. The medical device as defined in claim 1, wherein the at least one ethanol indicium indicates a percentage concentration of ethanol that the medical device can be acceptably exposed to.
  • 13. The medical device as defined in claim 1, wherein the at least one ethanol indicium is included on a tube clamp of an extension tube of the medical device.
  • 14. A catheter for accessing an internal portion of a patient, comprising: a peripherally-inserted central catheter;a catheter tube defining at least one lumen; andat least one ethanol indicium included with the catheter, the at least one ethanol indicium perceptible by an observer to indicate a compatibility of the catheter with ethanol; wherein the catheter further includes at least one extension leg operably attached to the catheter tube via a colored bifurcation, the colored bifurcation substantially colored yellow to serve as the at least one ethanol indicium; wherein each extension leg further includes a tube clamp, at least one tube clamp being colored and further including an alphanumeric marking to also serve as the at least one ethanol indicium; and wherein the alphanumeric marking includes the letters “ETOH” to indicate that the catheter can be fluid locked with ethanol.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a continuation-in-part of U.S. patent application Ser. No. 11/937,302, filed Nov. 8, 2007, and titled “Resource Information Key for an Insertable Medical Device,” which claims the benefit of U.S. Provisional Patent Application No. 60/864,806, filed Nov. 8, 2006, and titled “Medical Device Uniform Resource Identifier.” This application also claims the benefit of U.S. Provisional Patent Application No. 61/614,939, filed Mar. 23, 2012, and titled “Indicia Informative of Ethanol Locking Capability in a Catheter.” Each of the aforementioned applications is incorporated herein by reference in its entirety.

US Referenced Citations (808)
Number Name Date Kind
445896 Kinsman Feb 1891 A
546440 Tufts Sep 1895 A
574387 Buckler Jan 1897 A
611357 Dembinski Sep 1898 A
966696 Merrill Aug 1910 A
D44302 Director Jul 1913 S
1713267 Crowley May 1929 A
2029553 Bartischi et al. Feb 1936 A
D130852 Rothschild Dec 1941 S
2433480 Rendich Dec 1947 A
2891689 Gould Jun 1959 A
D198453 Weichselbaum Jun 1964 S
3159175 Macmillan Dec 1964 A
3211431 Meysembourg et al. Oct 1965 A
3293663 Cronin Dec 1966 A
3341417 Sinaiko Sep 1967 A
3477438 Allen et al. Nov 1969 A
3518428 Ring Jun 1970 A
3525357 Koreski Aug 1970 A
3529633 Vailancourt Sep 1970 A
3540670 Rissberger Nov 1970 A
3541438 Nelsen et al. Nov 1970 A
3643358 Morderosian Feb 1972 A
D223340 Brounn Apr 1972 S
3669323 Harker et al. Jun 1972 A
3674183 Venable et al. Jul 1972 A
3811466 Ohringer May 1974 A
3829904 Ling et al. Aug 1974 A
3831549 Parsons Aug 1974 A
3831583 Edmunds, Jr. et al. Aug 1974 A
3840009 Michaels et al. Oct 1974 A
3853127 Spademan Dec 1974 A
3891997 Herbert Jul 1975 A
3915162 Miller Oct 1975 A
3919724 Sanders et al. Nov 1975 A
3922726 Trentani et al. Dec 1975 A
3951147 Tucker et al. Apr 1976 A
3955594 Snow May 1976 A
3971376 Wichterle Jul 1976 A
4027391 Samis Jun 1977 A
4035653 Karasko Jul 1977 A
4121108 Manor Oct 1978 A
4123806 Amstutz et al. Nov 1978 A
4143853 Abramson Mar 1979 A
4168586 Samis Sep 1979 A
4181132 Parks Jan 1980 A
4190040 Schulte Feb 1980 A
4190057 Hill et al. Feb 1980 A
4194122 Mitchell et al. Mar 1980 A
4196731 Laurin et al. Apr 1980 A
4202349 Jones May 1980 A
4222374 Sampson et al. Sep 1980 A
4233964 Jefferts et al. Nov 1980 A
4274006 Caine Jun 1981 A
D263335 Bujan Mar 1982 S
4349498 Ellis et al. Sep 1982 A
4361153 Slocum et al. Nov 1982 A
4405305 Stephen et al. Sep 1983 A
4406567 Samis Sep 1983 A
4425119 Berglund Jan 1984 A
4445896 Gianturco May 1984 A
4447237 Frisch et al. May 1984 A
4450592 Niederer et al. May 1984 A
4450985 Beard May 1984 A
4456011 Warnecke Jun 1984 A
4469483 Becker et al. Sep 1984 A
4479798 Parks Oct 1984 A
4494545 Slocum et al. Jan 1985 A
4506676 Duska Mar 1985 A
4529635 Sheldon Jul 1985 A
4543088 Bootman et al. Sep 1985 A
4549879 Groshong et al. Oct 1985 A
4559043 Whitehouse et al. Dec 1985 A
4559046 Groshong et al. Dec 1985 A
4560375 Schulte et al. Dec 1985 A
4569675 Prosl et al. Feb 1986 A
4571749 Fischell Feb 1986 A
4576595 Aas et al. Mar 1986 A
4610665 Matsumoto et al. Sep 1986 A
4612877 Hayes et al. Sep 1986 A
4626244 Reinicke Dec 1986 A
4627844 Schmitt Dec 1986 A
4634427 Hannula et al. Jan 1987 A
4636194 Schulte et al. Jan 1987 A
4636213 Pakiam Jan 1987 A
4645495 Vaillancourt Feb 1987 A
4653508 Cosman Mar 1987 A
4655765 Swift Apr 1987 A
4657024 Coneys Apr 1987 A
4662652 Hargis May 1987 A
4668221 Luther May 1987 A
4671796 Groshong et al. Jun 1987 A
4673394 Fenton, Jr. et al. Jun 1987 A
4681560 Schulte et al. Jul 1987 A
4684365 Reinicke Aug 1987 A
4685447 Iversen et al. Aug 1987 A
4685905 Jeanneret nee Aab Aug 1987 A
4692146 Hilger Sep 1987 A
4695273 Brown Sep 1987 A
4697595 Breyer et al. Oct 1987 A
4701166 Groshong et al. Oct 1987 A
4704103 Stober et al. Nov 1987 A
4707389 Ward Nov 1987 A
4710167 Lazorthes Dec 1987 A
4710174 Moden et al. Dec 1987 A
4718894 Lazorthes Jan 1988 A
4723947 Konopka Feb 1988 A
4728894 Yoda et al. Mar 1988 A
4743231 Kay et al. May 1988 A
4753640 Nichols et al. Jun 1988 A
4755173 Konopka et al. Jul 1988 A
4760837 Petit Aug 1988 A
4762517 McIntyre et al. Aug 1988 A
4767410 Moden et al. Aug 1988 A
4772270 Wiita et al. Sep 1988 A
4772276 Wiita et al. Sep 1988 A
4773552 Boege et al. Sep 1988 A
4778452 Moden et al. Oct 1988 A
4781680 Redmond et al. Nov 1988 A
4781685 Lehmann et al. Nov 1988 A
4781695 Dalton Nov 1988 A
4784646 Feingold Nov 1988 A
4802885 Weeks et al. Feb 1989 A
4804054 Howson et al. Feb 1989 A
4820273 Reinicke Apr 1989 A
4822341 Colone Apr 1989 A
4840615 Hancock et al. Jun 1989 A
4848346 Crawford Jul 1989 A
4857053 Dalton Aug 1989 A
4861341 Woodburn Aug 1989 A
4863470 Carter Sep 1989 A
4886501 Johnston et al. Dec 1989 A
4886502 Poirier et al. Dec 1989 A
4892518 Cupp et al. Jan 1990 A
4897081 Poirier et al. Jan 1990 A
4904241 Bark Feb 1990 A
4905709 Bieganski et al. Mar 1990 A
4908029 Bark et al. Mar 1990 A
4909250 Smith Mar 1990 A
4915690 Cone et al. Apr 1990 A
4928298 Tanaka May 1990 A
4929236 Sampson May 1990 A
4955861 Enegren et al. Sep 1990 A
4961267 Herzog Oct 1990 A
4963133 Whipple Oct 1990 A
4966583 Debbas Oct 1990 A
4973319 Melsky Nov 1990 A
4983162 Metais et al. Jan 1991 A
5002735 Alberhasky et al. Mar 1991 A
5006115 McDonald Apr 1991 A
5009391 Steigerwald Apr 1991 A
5009644 McDonald Apr 1991 A
5013298 Moden et al. May 1991 A
5041098 Loiterman et al. Aug 1991 A
5044955 Jagmin Sep 1991 A
5045060 Melsky et al. Sep 1991 A
5045064 Idriss Sep 1991 A
5053013 Ensminger et al. Oct 1991 A
5059186 Yamamoto et al. Oct 1991 A
5069206 Crosbie Dec 1991 A
5084015 Moriuchi Jan 1992 A
5085216 Henley, Jr. et al. Feb 1992 A
5090066 Schoepe et al. Feb 1992 A
5092849 Sampson Mar 1992 A
5108317 Beinhaur et al. Apr 1992 A
5108375 Harrison et al. Apr 1992 A
5108377 Cone et al. Apr 1992 A
5112301 Fenton, Jr. et al. May 1992 A
5112303 Pudenz et al. May 1992 A
5129891 Young Jul 1992 A
5137529 Watson et al. Aug 1992 A
5147483 Melsky et al. Sep 1992 A
5152753 Laguette et al. Oct 1992 A
5156600 Young Oct 1992 A
5158547 Doan et al. Oct 1992 A
5167629 Vertenstein et al. Dec 1992 A
5167633 Mann et al. Dec 1992 A
5167638 Felix et al. Dec 1992 A
5169393 Moorehead et al. Dec 1992 A
5171228 McDonald Dec 1992 A
5176653 Metals Jan 1993 A
5176662 Bartholomew et al. Jan 1993 A
5178612 Fenton, Jr. Jan 1993 A
5180365 Ensminger et al. Jan 1993 A
5185003 Brethauer Feb 1993 A
5189690 Samuel Feb 1993 A
5193106 DeSena Mar 1993 A
5195122 Fabian Mar 1993 A
5195123 Clement Mar 1993 A
5201715 Masters Apr 1993 A
5201722 Moorehead et al. Apr 1993 A
5203771 Melker et al. Apr 1993 A
5203777 Lee Apr 1993 A
5205834 Moorehead et al. Apr 1993 A
5207644 Strecker May 1993 A
5213574 Tucker May 1993 A
5215537 Lynn et al. Jun 1993 A
5222499 Allen et al. Jun 1993 A
D337637 Tucker Jul 1993 S
5224938 Fenton, Jr. Jul 1993 A
5242415 Kantrowitz et al. Sep 1993 A
5246462 Bekki et al. Sep 1993 A
5249598 Schmidt Oct 1993 A
5263930 Ensminger Nov 1993 A
D342134 Mongeon Dec 1993 S
5281199 Ensminger et al. Jan 1994 A
5281205 McPherson Jan 1994 A
5290263 Wigness et al. Mar 1994 A
5295658 Atkinson et al. Mar 1994 A
5299253 Wessels Mar 1994 A
5300048 Drewes, Jr. et al. Apr 1994 A
5309863 Leeb, Jr. May 1994 A
5312337 Flaherty et al. May 1994 A
5318545 Tucker Jun 1994 A
5320100 Herweck et al. Jun 1994 A
5328480 Melker et al. Jul 1994 A
5332398 Miller et al. Jul 1994 A
5336194 Polaschegg et al. Aug 1994 A
5338398 Szwejkowski et al. Aug 1994 A
5350360 Ensminger et al. Sep 1994 A
5352204 Ensminger Oct 1994 A
5356381 Ensminger et al. Oct 1994 A
5360407 Leonard et al. Nov 1994 A
5383223 Inokuchi Jan 1995 A
5383233 Russell Jan 1995 A
5383585 Weiss Jan 1995 A
5383858 Reilly et al. Jan 1995 A
D355240 Gladfelter et al. Feb 1995 S
5387192 Glantz et al. Feb 1995 A
5394457 Leibinger et al. Feb 1995 A
5395324 Hinrichs et al. Mar 1995 A
5396925 Poli Mar 1995 A
5397329 Allen Mar 1995 A
5399168 Wadsworth, Jr. et al. Mar 1995 A
5405402 Dye et al. Apr 1995 A
5417565 Long May 1995 A
5417656 Ensminger et al. May 1995 A
5421814 Geary Jun 1995 A
5423334 Jordan Jun 1995 A
5425762 Muller Jun 1995 A
5453097 Paradis Sep 1995 A
5456698 Byland et al. Oct 1995 A
5476451 Ensminger et al. Dec 1995 A
5476460 Montalvo Dec 1995 A
5476880 Cooke et al. Dec 1995 A
5484402 Saravia et al. Jan 1996 A
5503630 Ensminger et al. Apr 1996 A
5507813 Dowd et al. Apr 1996 A
5509805 Jagmin Apr 1996 A
5513637 Twiss et al. May 1996 A
5514103 Srisathapat et al. May 1996 A
5520632 Leveen et al. May 1996 A
5520643 Ensminger et al. May 1996 A
5527277 Ensminger et al. Jun 1996 A
5527278 Ensminger et al. Jun 1996 A
5527307 Srisathapat et al. Jun 1996 A
5531684 Ensminger et al. Jul 1996 A
5542923 Ensminger et al. Aug 1996 A
5545143 Fischell Aug 1996 A
5554117 Ensminger et al. Sep 1996 A
5556381 Ensminger et al. Sep 1996 A
5558641 Glantz et al. Sep 1996 A
5558829 Petrick Sep 1996 A
5562617 Finch, Jr. et al. Oct 1996 A
5562618 Cai et al. Oct 1996 A
5575770 Melsky et al. Nov 1996 A
5593028 Haber et al. Jan 1997 A
5593434 Williams Jan 1997 A
5607393 Ensminger et al. Mar 1997 A
5607407 Tolkoff et al. Mar 1997 A
5613945 Cai et al. Mar 1997 A
5620419 Lui et al. Apr 1997 A
5632729 Cai et al. May 1997 A
5637102 Tolkoff et al. Jun 1997 A
5638832 Singer et al. Jun 1997 A
5647855 Trooskin Jul 1997 A
RE35601 Eckenhoff Sep 1997 E
5662600 Watson et al. Sep 1997 A
5662612 Niehoff Sep 1997 A
5662616 Bousquet Sep 1997 A
5676146 Scarborough Oct 1997 A
5695490 Flaherty et al. Dec 1997 A
5702128 Maxim et al. Dec 1997 A
5702363 Flaherty Dec 1997 A
5704915 Melsky et al. Jan 1998 A
5707357 Mikhail et al. Jan 1998 A
5709668 Wacks Jan 1998 A
5713844 Peyman Feb 1998 A
5713858 Heruth et al. Feb 1998 A
5713859 Finch, Jr. et al. Feb 1998 A
5718382 Jaeger Feb 1998 A
5718682 Tucker Feb 1998 A
5725507 Petrick Mar 1998 A
5733336 Neuenfeldt et al. Mar 1998 A
5733400 Gore et al. Mar 1998 A
5741228 Lambrecht et al. Apr 1998 A
5743873 Cai et al. Apr 1998 A
5743891 Tolkoff et al. Apr 1998 A
5746460 Marohl et al. May 1998 A
5755780 Finch, Jr. et al. May 1998 A
5758667 Slettenmark Jun 1998 A
5769823 Otto Jun 1998 A
5773552 Hutchings et al. Jun 1998 A
5776188 Shepherd et al. Jul 1998 A
5792104 Speckman et al. Aug 1998 A
5792116 Berg et al. Aug 1998 A
5792123 Ensminger Aug 1998 A
5797886 Roth et al. Aug 1998 A
5810789 Powers et al. Sep 1998 A
5814016 Valley et al. Sep 1998 A
5824071 Nelson et al. Oct 1998 A
5830172 Leveen et al. Nov 1998 A
5833654 Powers et al. Nov 1998 A
5835563 Navab et al. Nov 1998 A
5836935 Ashton et al. Nov 1998 A
5840063 Flaherty Nov 1998 A
5843069 Butler et al. Dec 1998 A
5848989 Villani Dec 1998 A
5853394 Tolkoff et al. Dec 1998 A
5868702 Stevens et al. Feb 1999 A
5879322 Lattin et al. Mar 1999 A
5882341 Bousquet Mar 1999 A
5882353 VanBeek et al. Mar 1999 A
5895424 Steele, Sr. et al. Apr 1999 A
5897528 Schultz Apr 1999 A
5899856 Schoendorfer et al. May 1999 A
5904934 Maruyama et al. May 1999 A
5906592 Kriesel et al. May 1999 A
5906596 Tallarida May 1999 A
5908413 Lange et al. Jun 1999 A
5908414 Otto et al. Jun 1999 A
5911706 Estabrook et al. Jun 1999 A
5913998 Butler et al. Jun 1999 A
5916263 Goicoechea et al. Jun 1999 A
5919160 Sanfilippo, II Jul 1999 A
5925017 Kriesel et al. Jul 1999 A
5925030 Gross et al. Jul 1999 A
5927345 Samson Jul 1999 A
5928197 Niehoff Jul 1999 A
5928744 Heilmann et al. Jul 1999 A
5931829 Burbank et al. Aug 1999 A
5941856 Kovacs et al. Aug 1999 A
5944023 Johnson et al. Aug 1999 A
5944688 Lois Aug 1999 A
5944698 Fischer et al. Aug 1999 A
5944712 Frassica et al. Aug 1999 A
D413672 Fogarty Sep 1999 S
5947953 Ash et al. Sep 1999 A
5951512 Dalton Sep 1999 A
5951522 Rosato et al. Sep 1999 A
5951929 Wilson Sep 1999 A
5954687 Baudino Sep 1999 A
5954691 Prosl Sep 1999 A
5957890 Mann et al. Sep 1999 A
5961497 Larkin Oct 1999 A
5968011 Larsen et al. Oct 1999 A
5970162 Kawashima Oct 1999 A
5989216 Johnson et al. Nov 1999 A
5989239 Finch et al. Nov 1999 A
5989641 Oulie Nov 1999 A
5997524 Burbank et al. Dec 1999 A
6007516 Burbank et al. Dec 1999 A
6013051 Nelson Jan 2000 A
6013058 Prosl et al. Jan 2000 A
6017331 Watts et al. Jan 2000 A
6022335 Ramadan Feb 2000 A
6033389 Cornish Mar 2000 A
6039712 Fogarty et al. Mar 2000 A
6056717 Finch et al. May 2000 A
6077756 Lin et al. Jun 2000 A
6086555 Eliasen et al. Jul 2000 A
6090066 Schnell Jul 2000 A
6099508 Bousquet Aug 2000 A
6102884 Squitieri Aug 2000 A
6113572 Gailey et al. Sep 2000 A
6120492 Finch et al. Sep 2000 A
6152909 Bagaoisan et al. Nov 2000 A
6161033 Kuhn Dec 2000 A
6171198 Lizama Troncoso et al. Jan 2001 B1
6171298 Matsuura et al. Jan 2001 B1
6186982 Gross et al. Feb 2001 B1
6190352 Haarala et al. Feb 2001 B1
6193684 Burbank et al. Feb 2001 B1
6198807 DeSena Mar 2001 B1
6200338 Solomon et al. Mar 2001 B1
6203570 Baeke Mar 2001 B1
6210366 Sanfilippo, II Apr 2001 B1
6213973 Eliasen et al. Apr 2001 B1
6228088 Miller et al. May 2001 B1
6251059 Apple et al. Jun 2001 B1
D445175 Bertheas Jul 2001 S
6261259 Bell Jul 2001 B1
6269148 Jessop et al. Jul 2001 B1
6272370 Gillies et al. Aug 2001 B1
6287293 Jones et al. Sep 2001 B1
6290677 Arai et al. Sep 2001 B1
6305413 Fischer et al. Oct 2001 B1
6306124 Jones et al. Oct 2001 B1
D450115 Bertheas Nov 2001 S
6315762 Recinella et al. Nov 2001 B1
6332874 Eliasen et al. Dec 2001 B1
6355021 Nielsen et al. Mar 2002 B1
6356782 Sirimanne et al. Mar 2002 B1
6361557 Gittings et al. Mar 2002 B1
6398764 Finch, Jr. et al. Jun 2002 B1
6419680 Cosman et al. Jul 2002 B1
6450937 Mercereau et al. Sep 2002 B1
6473638 Ferek-Petric Oct 2002 B2
6475516 DiCosmo et al. Nov 2002 B2
6478783 Moorehead Nov 2002 B1
6482217 Pintor et al. Nov 2002 B1
6494867 Elver et al. Dec 2002 B1
6497062 Koopman et al. Dec 2002 B1
6500155 Sasso Dec 2002 B2
6503228 Li et al. Jan 2003 B1
6527754 Tallarida et al. Mar 2003 B1
6537255 Raines Mar 2003 B1
RE38074 Recinella et al. Apr 2003 E
6562023 Marrs et al. May 2003 B1
6572583 Olsen et al. Jun 2003 B1
6582418 Verbeek et al. Jun 2003 B1
6592571 Verbeek et al. Jul 2003 B1
6610031 Chin Aug 2003 B1
6613002 Clark et al. Sep 2003 B1
6613662 Wark et al. Sep 2003 B2
6626936 Stinson Sep 2003 B2
D480942 Ishida et al. Oct 2003 S
6629950 Levin Oct 2003 B1
6632217 Harper et al. Oct 2003 B2
6652486 Bialecki et al. Nov 2003 B2
6652503 Bradley Nov 2003 B1
6663646 Shah Dec 2003 B1
6676633 Smith et al. Jan 2004 B2
6697664 Kienzle, III et al. Feb 2004 B2
6705316 Blythe et al. Mar 2004 B2
6719721 Okazaki et al. Apr 2004 B1
6719739 Verbeek et al. Apr 2004 B2
6726063 Stull et al. Apr 2004 B2
6738531 Funahashi May 2004 B1
6755842 Kanner et al. Jun 2004 B2
6758841 Haarala et al. Jul 2004 B2
6767356 Kanner et al. Jul 2004 B2
6784783 Scoggin et al. Aug 2004 B2
6808738 DiTizio et al. Oct 2004 B2
D498894 Gould Nov 2004 S
6826257 Sayre et al. Nov 2004 B2
6827709 Fujii Dec 2004 B2
6852106 Watson et al. Feb 2005 B2
6856055 Michaels et al. Feb 2005 B2
6878136 Fleury et al. Apr 2005 B2
6878137 Benchetrit Apr 2005 B2
6929631 Brugger et al. Aug 2005 B1
6949084 Marggi et al. Sep 2005 B2
6953453 Recinella et al. Oct 2005 B2
6962577 Tallarida et al. Nov 2005 B2
6962580 Adams et al. Nov 2005 B2
6994315 Ryan et al. Feb 2006 B2
6997914 Smith et al. Feb 2006 B2
7008377 Beane et al. Mar 2006 B2
7008412 Maginot Mar 2006 B2
7016456 Basu et al. Mar 2006 B2
7018361 Gillespie, Jr. et al. Mar 2006 B2
D518573 French Apr 2006 S
7033335 Haarala et al. Apr 2006 B2
7033339 Lynn Apr 2006 B1
7044942 Jolly et al. May 2006 B2
7056316 Burbank et al. Jun 2006 B1
7070591 Adams et al. Jul 2006 B2
7072704 Bucholz Jul 2006 B2
7074232 Kanner et al. Jul 2006 B2
7076305 Imran et al. Jul 2006 B2
7083593 Stultz Aug 2006 B2
7108686 Burke et al. Sep 2006 B2
7123690 Brown et al. Oct 2006 B1
7124570 Blatter et al. Oct 2006 B2
7127040 Sayre et al. Oct 2006 B2
7131962 Estabrook et al. Nov 2006 B1
7140769 Kay Nov 2006 B2
7186236 Gibson et al. Mar 2007 B2
7191011 Cantlon Mar 2007 B2
7198631 Kanner et al. Apr 2007 B2
7214207 Lynch et al. May 2007 B2
7214215 Heinzerling et al. May 2007 B2
7223257 Shubayev et al. May 2007 B2
7229417 Foerster et al. Jun 2007 B2
7232429 Moreci Jun 2007 B2
7235067 Morris et al. Jun 2007 B2
D546440 Burnside Jul 2007 S
7242982 Singhal et al. Jul 2007 B2
7248668 Galkin Jul 2007 B2
7252469 Zaluzec et al. Aug 2007 B2
7252649 Sherry Aug 2007 B2
7261705 Edoga et al. Aug 2007 B2
D550355 Racz et al. Sep 2007 S
D554253 Kornerup Oct 2007 S
7275682 Excoffier et al. Oct 2007 B2
7276075 Callas et al. Oct 2007 B1
D556153 Burnside Nov 2007 S
7306579 Fujii Dec 2007 B2
7311702 Tallarida et al. Dec 2007 B2
7318816 Bobroff et al. Jan 2008 B2
7318818 Yashiro et al. Jan 2008 B2
7322953 Redinger Jan 2008 B2
D562442 Blateri Feb 2008 S
D562443 Zinn et al. Feb 2008 S
7331130 Schweikert Feb 2008 B2
7331948 Skarda Feb 2008 B2
7333013 Berger Feb 2008 B2
D564449 Dewberry Mar 2008 S
7347838 Kulli Mar 2008 B2
7347843 Adams et al. Mar 2008 B2
7351233 Parks Apr 2008 B2
7377915 Rasmussen et al. May 2008 B2
D574950 Zawacki et al. Aug 2008 S
7413564 Morris et al. Aug 2008 B2
D578203 Bizup Oct 2008 S
7445614 Bunodiere et al. Nov 2008 B2
D582032 Bizup et al. Dec 2008 S
7465847 Fabian Dec 2008 B2
7485148 Wozencroft et al. Feb 2009 B2
7497850 Halili Mar 2009 B2
D590499 Chesnin Apr 2009 S
7552853 Mas et al. Jun 2009 B2
7553298 Hunt et al. Jun 2009 B2
D595892 Smith et al. Jul 2009 S
7563025 Kay Jul 2009 B2
7628776 Gibson et al. Dec 2009 B2
7658196 Ferreri et al. Feb 2010 B2
D612479 Zawacki et al. Mar 2010 S
D613394 Linden Apr 2010 S
7713251 Tallarida et al. May 2010 B2
7722580 Dicarlo et al. May 2010 B2
D619242 Zinn et al. Jul 2010 S
7785302 Powers Aug 2010 B2
7803143 Tallarida et al. Sep 2010 B2
7806888 Frassica Oct 2010 B2
7811266 Eliasen Oct 2010 B2
D629503 Caffey et al. Dec 2010 S
7846139 Zinn et al. Dec 2010 B2
7850660 Uth et al. Dec 2010 B2
7862546 Conlon et al. Jan 2011 B2
D634840 Lombardi, III et al. Mar 2011 S
7909804 Stats Mar 2011 B2
7931619 Diamond et al. Apr 2011 B2
7947022 Amin et al. May 2011 B2
7959615 Stats et al. Jun 2011 B2
7972314 Bizup et al. Jul 2011 B2
8007474 Uth et al. Aug 2011 B2
8021324 Bizup et al. Sep 2011 B2
8025639 Powers et al. Sep 2011 B2
8029482 Maniar et al. Oct 2011 B2
D650475 Smith et al. Dec 2011 S
8075536 Gray et al. Dec 2011 B2
8092435 Beling et al. Jan 2012 B2
8147455 Butts et al. Apr 2012 B2
8172894 Schmid et al. May 2012 B2
8172896 McNamara et al. May 2012 B2
8177762 Beasley et al. May 2012 B2
8182453 Eliasen May 2012 B2
8197454 Mann et al. Jun 2012 B2
8202259 Evans et al. Jun 2012 B2
8257325 Schweikert et al. Sep 2012 B2
D676955 Orome Feb 2013 S
8366687 Girard et al. Feb 2013 B2
8377034 Tallarida et al. Feb 2013 B2
8382723 Powers et al. Feb 2013 B2
8382724 Maniar et al. Feb 2013 B2
8409153 Tallarida et al. Apr 2013 B2
8475417 Powers et al. Jul 2013 B2
8545460 Beasley et al. Oct 2013 B2
8585663 Powers et al. Nov 2013 B2
8603052 Powers et al. Dec 2013 B2
8608712 Bizup et al. Dec 2013 B2
8608713 Beasley et al. Dec 2013 B2
8641676 Butts et al. Feb 2014 B2
8641688 Powers et al. Feb 2014 B2
8805478 Powers et al. Aug 2014 B2
8852160 Schweikert et al. Oct 2014 B2
8932271 Hamatake et al. Jan 2015 B2
8939947 Maniar et al. Jan 2015 B2
8998860 Sheetz et al. Apr 2015 B2
20010016717 Haarala et al. Aug 2001 A1
20010047165 Makower et al. Nov 2001 A1
20010051766 Gazdzinski Dec 2001 A1
20010053889 Marggi et al. Dec 2001 A1
20010056266 Tallarida et al. Dec 2001 A1
20020013557 Sherry Jan 2002 A1
20020052576 Massengale May 2002 A1
20020055715 Young et al. May 2002 A1
20020095205 Edwin et al. Jul 2002 A1
20020121530 Socier Sep 2002 A1
20020138068 Watson et al. Sep 2002 A1
20020169418 Menzi et al. Nov 2002 A1
20020173769 Gray et al. Nov 2002 A1
20020173772 Olsen Nov 2002 A1
20020183846 Kuslich et al. Dec 2002 A1
20020188282 Greenberg Dec 2002 A1
20030028173 Forsberg Feb 2003 A1
20030093029 McGuckin et al. May 2003 A1
20030109856 Sherry Jun 2003 A1
20030130627 Smith et al. Jul 2003 A1
20030139812 Garcia et al. Jul 2003 A1
20030141477 Miller Jul 2003 A1
20030181878 Tallarida et al. Sep 2003 A1
20030191452 Meglin et al. Oct 2003 A1
20030208184 Burke et al. Nov 2003 A1
20030216694 Tollini Nov 2003 A1
20030217659 Yamamoto et al. Nov 2003 A1
20040002693 Bright et al. Jan 2004 A1
20040006316 Patton Jan 2004 A1
20040020462 Sauler et al. Feb 2004 A1
20040020492 Dubrul et al. Feb 2004 A1
20040024361 Fago et al. Feb 2004 A1
20040044306 Lynch et al. Mar 2004 A1
20040054352 Adams et al. Mar 2004 A1
20040056266 Suh et al. Mar 2004 A1
20040064110 Forsell Apr 2004 A1
20040073196 Adams et al. Apr 2004 A1
20040078000 Borchard et al. Apr 2004 A1
20040086568 Ditizio et al. May 2004 A1
20040087877 Besz et al. May 2004 A1
20040087885 Kawano et al. May 2004 A1
20040106878 Skujins et al. Jun 2004 A1
20040106891 Langan et al. Jun 2004 A1
20040106942 Taylor et al. Jun 2004 A1
20040133173 Edoga et al. Jul 2004 A1
20040156472 Galkin Aug 2004 A1
20040157952 Soffiati et al. Aug 2004 A1
20040158207 Hunn et al. Aug 2004 A1
20040167543 Mazzocchi et al. Aug 2004 A1
20040176743 Morris et al. Sep 2004 A1
20040186444 Daly et al. Sep 2004 A1
20040199129 DiMatteo Oct 2004 A1
20040199220 Cantlon Oct 2004 A1
20040204692 Eliasen Oct 2004 A1
20040204759 Blom et al. Oct 2004 A1
20040225254 Tanaka et al. Nov 2004 A1
20040254536 Conlon et al. Dec 2004 A1
20040254537 Conlon et al. Dec 2004 A1
20050010176 Dikeman et al. Jan 2005 A1
20050010286 Vijay Jan 2005 A1
20050027234 Waggoner et al. Feb 2005 A1
20050027261 Weaver et al. Feb 2005 A1
20050038390 Fago et al. Feb 2005 A1
20050049553 Triplett et al. Mar 2005 A1
20050070875 Kulessa Mar 2005 A1
20050075614 Bunodiere et al. Apr 2005 A1
20050080401 Peavey Apr 2005 A1
20050085778 Parks Apr 2005 A1
20050113806 De Carvalho et al. May 2005 A1
20050124980 Sanders Jun 2005 A1
20050131352 Conlon et al. Jun 2005 A1
20050148866 Gunderson Jul 2005 A1
20050148869 Masuda Jul 2005 A1
20050148956 Conlon et al. Jul 2005 A1
20050148957 Girard et al. Jul 2005 A1
20050152841 Sayre et al. Jul 2005 A1
20050171502 Daly et al. Aug 2005 A1
20050182857 Kong Aug 2005 A1
20050209573 Brugger et al. Sep 2005 A1
20050215874 Wang et al. Sep 2005 A1
20050241203 Lizotte et al. Nov 2005 A1
20050256451 Adams et al. Nov 2005 A1
20050256500 Fujii Nov 2005 A1
20050277899 Conlon et al. Dec 2005 A1
20050283119 Uth et al. Dec 2005 A1
20060009788 Freeman et al. Jan 2006 A1
20060017341 Hahn et al. Jan 2006 A1
20060084929 Eliasen Apr 2006 A1
20060089619 Ginggen Apr 2006 A1
20060100592 Eliasen May 2006 A1
20060116648 Hamatake Jun 2006 A1
20060171980 Helmus et al. Aug 2006 A1
20060173410 Moberg et al. Aug 2006 A1
20060173424 Conlon Aug 2006 A1
20060178647 Stats Aug 2006 A1
20060178648 Barron et al. Aug 2006 A1
20060184141 Smith et al. Aug 2006 A1
20060184142 Schon et al. Aug 2006 A1
20060217359 Wentworth et al. Sep 2006 A1
20060217659 Patton Sep 2006 A1
20060217668 Schulze et al. Sep 2006 A1
20060224128 Lurvey et al. Oct 2006 A1
20060224129 Beasley et al. Oct 2006 A1
20060224235 Rucker Oct 2006 A1
20060241465 Huennekens et al. Oct 2006 A1
20060247584 Sheetz et al. Nov 2006 A1
20060253076 Butts et al. Nov 2006 A1
20060264897 Lobl et al. Nov 2006 A1
20060264898 Beasley et al. Nov 2006 A1
20060271012 Canaud et al. Nov 2006 A1
20062064898 Beasley et al. Nov 2006
20070003603 Karandikar et al. Jan 2007 A1
20070007839 Lin Jan 2007 A1
20070010881 Soye et al. Jan 2007 A1
20070016162 Burbank et al. Jan 2007 A1
20070049806 Adams et al. Mar 2007 A1
20070049876 Patton Mar 2007 A1
20070055290 Lober Mar 2007 A1
20070073250 Schneiter Mar 2007 A1
20070078391 Wortley et al. Apr 2007 A1
20070078416 Eliasen Apr 2007 A1
20070078432 Halseth et al. Apr 2007 A1
20070083111 Hossack et al. Apr 2007 A1
20070083156 Muto et al. Apr 2007 A1
20070100302 Dicarlo et al. May 2007 A1
20070112332 Harding et al. May 2007 A1
20070120683 Flippen et al. May 2007 A1
20070123831 Haindl et al. May 2007 A1
20070135775 Edoga et al. Jun 2007 A1
20070149920 Michels et al. Jun 2007 A1
20070149921 Michels et al. Jun 2007 A1
20070149947 Byrum Jun 2007 A1
20070161958 Glenn Jul 2007 A1
20070179456 Glenn Aug 2007 A1
20070185462 Byrum Aug 2007 A1
20070191773 Wojcik Aug 2007 A1
20070207335 Karandikar et al. Sep 2007 A1
20070208313 Conlon et al. Sep 2007 A1
20070219510 Zinn et al. Sep 2007 A1
20070233017 Zinn et al. Oct 2007 A1
20070233018 Bizup et al. Oct 2007 A1
20070255226 Tennican et al. Nov 2007 A1
20070255234 Haase et al. Nov 2007 A1
20070270691 Bailey et al. Nov 2007 A1
20070270770 Bizup Nov 2007 A1
20070276344 Bizup et al. Nov 2007 A1
20070276355 Nielsen et al. Nov 2007 A1
20070282308 Bell Dec 2007 A1
20070293800 McMaken et al. Dec 2007 A1
20070299408 Alferness et al. Dec 2007 A1
20080004642 Birk et al. Jan 2008 A1
20080008654 Clarke et al. Jan 2008 A1
20080015701 Garcia et al. Jan 2008 A1
20080039820 Sommers et al. Feb 2008 A1
20080048855 Berger Feb 2008 A1
20080108949 Beasley et al. May 2008 A1
20080114308 di Palma et al. May 2008 A1
20080133265 Silkaitis et al. Jun 2008 A1
20080137923 Spahn Jun 2008 A1
20080138387 Machiraju Jun 2008 A1
20080140025 Sheetz et al. Jun 2008 A1
20080208236 Hobbs et al. Aug 2008 A1
20080281279 Hoendervoogt et al. Nov 2008 A1
20080319398 Bizup Dec 2008 A1
20080319399 Schweikert et al. Dec 2008 A1
20080319405 Bizup Dec 2008 A1
20090024024 Zinn Jan 2009 A1
20090024098 Bizup et al. Jan 2009 A1
20090035582 Nakatani et al. Feb 2009 A1
20090118683 Hanson et al. May 2009 A1
20090156928 Evans et al. Jun 2009 A1
20090204072 Amin et al. Aug 2009 A1
20090204074 Powers et al. Aug 2009 A1
20090216216 Powers et al. Aug 2009 A1
20090221976 Linden Sep 2009 A1
20090227862 Smith et al. Sep 2009 A1
20090227951 Powers et al. Sep 2009 A1
20090227964 DiCarlo et al. Sep 2009 A1
20090264901 Franklin et al. Oct 2009 A1
20090322541 Jones et al. Dec 2009 A1
20100010339 Smith et al. Jan 2010 A1
20100042073 Oster et al. Feb 2010 A1
20100063451 Gray et al. Mar 2010 A1
20100069743 Sheetz et al. Mar 2010 A1
20100106094 Fisher et al. Apr 2010 A1
20100121283 Hamatake et al. May 2010 A1
20100211026 Sheetz et al. Aug 2010 A2
20100268165 Maniar et al. Oct 2010 A1
20100268174 Steinke et al. Oct 2010 A1
20110021922 Berard-Anderson et al. Jan 2011 A1
20110092921 Beling et al. Apr 2011 A1
20110098662 Zinn Apr 2011 A1
20110098663 Zinn Apr 2011 A1
20110118677 Wiley et al. May 2011 A1
20110183712 Eckstein et al. Jul 2011 A1
20110213700 Sant'Anselmo Sep 2011 A1
20110257609 Bizup et al. Oct 2011 A1
20110264058 Linden et al. Oct 2011 A1
20110271856 Fisher et al. Nov 2011 A1
20110275930 Jho et al. Nov 2011 A1
20110276015 Powers et al. Nov 2011 A1
20110288502 Hibdon et al. Nov 2011 A1
20110288503 Magalich et al. Nov 2011 A1
20110311337 Amin et al. Dec 2011 A1
20120018073 Maniar et al. Jan 2012 A1
20120059250 Gray et al. Mar 2012 A1
20120065622 Cornish et al. Mar 2012 A1
20120078201 Mikami Mar 2012 A1
20120078202 Beling et al. Mar 2012 A1
20120191071 Butts et al. Jul 2012 A1
20120226244 Beasley et al. Sep 2012 A1
20120259296 Sheetz et al. Oct 2012 A1
20120283560 Schweikert et al. Nov 2012 A1
20120302969 Wiley et al. Nov 2012 A1
20130165773 Powers et al. Jun 2013 A1
20130172733 Maniar et al. Jul 2013 A1
20130218103 Tallarida et al. Aug 2013 A1
20130225990 Powers et al. Aug 2013 A1
20130225991 Powers Aug 2013 A1
20130245574 Powers et al. Sep 2013 A1
20130338494 Wiley et al. Dec 2013 A1
20140081219 Powers et al. Mar 2014 A1
20140100534 Beasley et al. Apr 2014 A1
20140107619 Butts et al. Apr 2014 A1
20140330118 Powers et al. Nov 2014 A1
20150025478 Hibdon et al. Jan 2015 A1
20150112284 Hamatake et al. Apr 2015 A1
Foreign Referenced Citations (142)
Number Date Country
2008299945 Mar 2009 AU
2663853 Apr 2008 CA
2692142 Dec 2008 CA
2693972 Jan 2009 CA
102421469 Apr 2012 CN
102612343 Jul 2012 CN
3618390 Nov 1987 DE
3720414 Dec 1987 DE
42 25 524 Feb 1994 DE
29512576 Oct 1995 DE
10346470 May 2005 DE
0128525 Dec 1984 EP
0134745 Mar 1985 EP
0343910 Nov 1989 EP
0366814 May 1990 EP
0239244 Sep 1991 EP
0534782 Mar 1993 EP
0619101 Oct 1994 EP
1238682 Sep 2002 EP
1635899 Mar 2006 EP
2006019101 Dec 2006 EP
1858565 Nov 2007 EP
1874393 Jan 2008 EP
1896117 Mar 2008 EP
1998842 Dec 2008 EP
2004272 Dec 2008 EP
2018209 Jan 2009 EP
2081634 Jul 2009 EP
2164559 Mar 2010 EP
2167182 Mar 2010 EP
2180915 May 2010 EP
2190517 Jun 2010 EP
2308547 Apr 2011 EP
2320974 May 2011 EP
2324878 May 2011 EP
2324879 May 2011 EP
2324880 May 2011 EP
2365838 Sep 2011 EP
2571563 Mar 2013 EP
2601999 Jun 2013 EP
2324879 Jan 2014 EP
1509165 Jan 1968 FR
2508008 Dec 1982 FR
2809315 Nov 2001 FR
178998 May 1922 GB
749942 Jun 1956 GB
966137 Aug 1964 GB
1559140 Jan 1980 GB
2102398 Feb 1983 GB
2191701 Dec 1987 GB
2350352 Nov 2000 GB
62155857 Jul 1987 JP
62281966 Dec 1987 JP
64-011562 Jan 1989 JP
6296633 Oct 1994 JP
2000-79168 Mar 2000 JP
2000-079168 Mar 2000 JP
2002500076 Jan 2002 JP
2003-510136 Mar 2003 JP
2004-350937 Dec 2004 JP
2006025948 Feb 2006 JP
2007-533368 Nov 2007 JP
3142990 Jul 2008 JP
2008-539025 Nov 2008 JP
2012-523284 Oct 2012 JP
2013-510652 Mar 2013 JP
2013-526376 Jun 2013 JP
8600213 Jan 1986 WO
8911309 Nov 1989 WO
9001958 Mar 1990 WO
9206732 Apr 1992 WO
9300945 Jan 1993 WO
9305730 Apr 1993 WO
9308986 May 1993 WO
9405351 Mar 1994 WO
9515194 Jun 1995 WO
9516480 Jun 1995 WO
9701370 Jan 1997 WO
9706845 Feb 1997 WO
9711726 Apr 1997 WO
9723255 Jul 1997 WO
9726931 Jul 1997 WO
9817337 Apr 1998 WO
9818506 May 1998 WO
9831417 Jul 1998 WO
9934859 Jul 1999 WO
9938553 Aug 1999 WO
9942166 Aug 1999 WO
0012171 Mar 2000 WO
0016844 Mar 2000 WO
0033901 Jun 2000 WO
0123023 Apr 2001 WO
0160444 Aug 2001 WO
0195813 Dec 2001 WO
0247549 Jun 2002 WO
03084832 Oct 2003 WO
03090509 Nov 2003 WO
2004004800 Jan 2004 WO
2004028611 Apr 2004 WO
2004071555 Aug 2004 WO
2004091434 Oct 2004 WO
2005037055 Apr 2005 WO
2005068009 Jul 2005 WO
2005072627 Aug 2005 WO
2006078915 Jul 2006 WO
2006096686 Sep 2006 WO
2006116438 Nov 2006 WO
2006116613 Nov 2006 WO
2006130133 Dec 2006 WO
2006134100 Dec 2006 WO
2007041471 Apr 2007 WO
2007079024 Jul 2007 WO
2007092210 Aug 2007 WO
2007094898 Aug 2007 WO
2007098771 Sep 2007 WO
2007109164 Sep 2007 WO
2007126645 Nov 2007 WO
2007136538 Nov 2007 WO
2008008126 Jan 2008 WO
2008019236 Feb 2008 WO
2008048361 Apr 2008 WO
2008062173 May 2008 WO
2008063226 May 2008 WO
2008147760 Dec 2008 WO
2008157763 Dec 2008 WO
2009002839 Dec 2008 WO
2009012385 Jan 2009 WO
2009012395 Jan 2009 WO
2009035582 Mar 2009 WO
2009046439 Apr 2009 WO
2009046725 Apr 2009 WO
2009108669 Sep 2009 WO
2010030351 Mar 2010 WO
2010062633 Jun 2010 WO
2010118144 Oct 2010 WO
2011046604 Apr 2011 WO
2011053499 May 2011 WO
2011056619 May 2011 WO
2011062750 May 2011 WO
2011133950 Oct 2011 WO
2011146649 Nov 2011 WO
2014031763 Feb 2014 WO
Non-Patent Literature Citations (346)
Entry
Bard Access Systems, Bad Port, SlimPort, X-Port Instructions for Use, 24 pages, Oct. 2012.
Bard Access Systems, PowerPort and PowerLoc CT Guide, 11 pages, Dec. 2009.
Bard Access Systems, PowerPort and PowerLoc Product Brochure, 6 pages, © 2007.
Bard Access Systems, PowerPort CT Guide, 16 pages, Mar. 2007.
Bard Access Systems, PowerPort Guidelines for CT Technologists, 1 page, Feb. 2007.
Bard Access Systems, PowerPort Guidelines for CT Technologists, 1 page, Jul. 2006.
Bard Access Systems, PowerPort Guidelines for Nurses, 1 page, Feb. 2007.
Bard Access Systems, PowerPort Guidelines for Physicians, 1 page, Feb. 2007.
Bard Access Systems, PowerPort Prescription Pad, 1 page, © 2007.
Bard Access Systems, PowerPort™ Implantable Port Product Information, © 2007.
Bard Access Systems, When in Doubt, Scout!, 1 page, © 2007.
Biotronik, Stratos Cardiac Resynchronization Therapy Pacemakers Technical Manual, 179 pages, © 2008.
Boston Scientific, Xcela™ Power Injectable PICC Directions for Use, 12 pages, © 2007.
CN 200980153471.3 filed Jun. 30, 2011 Fourth Office Action dated Nov. 15, 2014.
CN 201080051911.7 filed May 16, 2012 Second Office Action dated Jul. 16, 2014.
EP 06845998.1 filed Dec. 21, 2006 Summons for Oral Proceedings dated Sep. 30, 2014.
EP 13158343.7 filed Mar. 8, 2013 Summons to Attend Oral Proceedings dated Oct. 20, 2014.
JP 2012-504826 filed Oct. 6, 2011 Second Office Action dated Nov. 17, 2014.
JP 2013-209156 filed Oct. 4, 2013 Non-Final Office Action dated Oct. 7, 2014.
MX/a/2011/004499 filed Apr. 28, 2011 Second Office Action dated May 25, 2014.
PFM Medical, Xcela™ Power Injectable Port Directions for Use, 15 pages, © 2008.
U.S. Appl. No. 12/917,323, filed Nov. 1, 2010 Non-Final Office Action dated Aug. 26, 2014.
U.S. Appl. No. 13/524,712, filed Jun. 15, 2012 Non-Final Office Action dated Aug. 21, 2014.
U.S. Appl. No. 13/524,712, filed Jun. 15, 2012 Notice of Allowance dated Dec. 12, 2014.
U.S. Appl. No. 13/571,088, filed Aug. 9, 2012 Non-Final Office Action dated Jan. 7, 2015.
U.S. Appl. No. 13/776,517, filed Feb. 25, 2013 Notice of Allowance dated Sep. 23, 2014.
U.S. Appl. No. 13/853,956, filed Mar. 29, 2013 Non-Final Office Action dated Sep. 15, 2014.
U.S. Appl. No. 13/853,961, filed Mar. 29, 2013 Non-Final Office Action dated Sep. 12, 2014.
CN 201080020088.3 filed Nov. 7, 2011 First Office Action dated Mar. 4, 2013.
ECRI Institute, Healthcare Product Comparison System, Dec. 2007.
EP 06751664.1 filed Apr. 27, 2006 First Examination Report dated Jul. 11, 2013.
EP 06845998.1 filed Dec. 21, 2006 Examination Report dated May 13, 2013.
EP 10183380.4 filed Apr. 25, 2006 European Search Report dated May 22, 2013.
EP 10183382.0 filed Apr. 25, 2006 European Search Report dated May 22, 2013.
EP 10183394.5 filed Apr. 25, 2006 European Search Report dated May 22, 2013.
EP 10183398.6 filed Apr. 25, 2006 European Search Report dated May 22, 2013.
EP 10762377.9 filed Oct. 5, 2011 Office Action dated Jul. 17, 2013.
EP 13158343.7 filed Mar. 8, 2013 Extended European Search Report dated May 14, 2013.
Ethanol Lock Technique for Prevention and Treatment of Central line-Associated Bloodstream Infections (Nebraska) Aug. 13, 2011, Accessed: Jun. 29, 2013 http://www.nebraskamed.com/app—files/pdf/careers/education-programs/asp/tnmc—etohlock—final.pdf.
JP 2012-156976 filed Jul. 12, 2012 Submission of Documents by Third Party dated May 14, 2013.
Medcomp Dialysis and Vascular Access Products (Medcomp) Jun. 30, 2009, Accessed Jun. 29, 2013 http://www.medcompnet.com/products/flipbook/pdf/PN2114G—Medcomp—Catalog.pdf.
PCT/US2013/031035 filed Mar. 13, 2013 International Search Report and Written Opinion dated Jun. 3, 2013.
Takeuchi, Syuhei et al., “Safety Considerations in the Power Injection of Contrast Medium via a Totally Implantable Central Venous Access System,” Japan Journal of Interventional Radiology vol. 20, No. 1, pp. 27-30, Jan. 2005.
U.S. Appl. No. 11/380,124, filed Apr. 25, 2006 Notice of Allowance dated Apr. 29, 2013.
U.S. Appl. No. 12/419,854, filed Apr. 7, 2009 Advisory Action dated May 17, 2013.
U.S. Appl. No. 12/419,854, filed Apr. 7, 2009 Final Office Action dated Feb. 14, 2013.
U.S. Appl. No. 12/420,007, filed Apr. 7, 2009 Final Office Action dated Mar. 22, 2013.
U.S. Appl. No. 12/917,323, filed Nov. 1, 2010 Advisory Action dated Apr. 10, 2013.
U.S. Appl. No. 13/438,586, filed Apr. 3, 2012 Advisory Action dated May 29, 2013.
U.S. Appl. No. 13/438,586, filed Apr. 3, 2012 Final Office Action dated Mar. 7, 2013.
U.S. Appl. No. 13/471,219, filed May 14, 2012 Non-Final Office Action dated Jul. 10, 2013.
U.S. Appl. No. 13/571,088, filed Aug. 9, 2012 Final Office Action dated Jul. 16, 2013.
U.S. Appl. No. 13/571,088, filed Aug. 9, 2012 Non-Final Office Action dated Feb. 27, 2013.
U.S. Appl. No. 13/776,451, filed Feb. 25, 2013 Non-Final Office Action dated Jul. 24, 2013.
U.S. Appl. No. 13/853,942, filed Mar. 29, 2013 Non-Final Office Action dated Jul. 26, 2013.
U.S. Appl. No. 95/002,089, filed Aug. 20, 2012 Action Closing Prosecution dated Jun. 12, 2013.
U.S. Appl. No. 95/002,090, filed Aug. 20, 2012 Action Closing Prosecution dated Jun. 12, 2013.
U.S. Appl. No. 95/002,092, filed Aug. 20, 2012 Action Closing Prosecution dated Jun. 12, 2013.
U.S. Appl. No. 12/267,160, filed Nov. 7, 2008 Examiner's Answer dated Dec. 5, 2012.
U.S. Appl. No. 12/267,160, filed Nov. 7, 2008 Final Office Action dated Jun. 1, 2012.
U.S. Appl. No. 12/267,160, filed Nov. 7, 2008 Non-Final Office Action dated Nov. 1, 2011.
U.S. Appl. No. 12/419,854, filed Apr. 7, 2009 Final Office Action dated Nov. 29, 2011.
U.S. Appl. No. 12/419,854, filed Apr. 7, 2009 Non-Final Office Action dated Aug. 5, 2011.
U.S. Appl. No. 12/419,854, filed Apr. 7, 2009 Non-Final Office Action dated Jun. 26, 2012.
U.S. Appl. No. 12/419,957, filed Apr. 7, 2009 Advisory Action dated Feb. 18, 2011.
U.S. Appl. No. 12/419,957, filed Apr. 7, 2009 Final Office Action dated Dec. 7, 2010.
U.S. Appl. No. 12/419,957, filed Apr. 7, 2009 Non-Final Office Action dated Feb. 18, 2010.
U.S. Appl. No. 12/419,957, filed Apr. 7, 2009 Non-Final Office Action dated Jul. 29, 2010.
U.S. Appl. No. 12/419,957, filed Apr. 7, 2009 Non-Final Office Action dated Jun. 30, 2009.
U.S. Appl. No. 12/419,957, filed Apr. 7, 2009 Notice of Allowance dated Mar. 7, 2011.
U.S. Appl. No. 12/420,007, filed Apr. 7, 2009 Non-Final Office Action dated Oct. 16, 2012.
U.S. Appl. No. 12/420,007, filed Apr. 7, 2009 Final Office Action dated Feb. 18, 2010.
U.S. Appl. No. 12/420,007, filed Apr. 7, 2009 Non-Final Office Action dated Jul. 14, 2009.
U.S. Appl. No. 12/420,028, filed Apr. 7, 2009 Non-Final Office Action dated Jan. 5, 2011.
U.S. Appl. No. 12/420,028, filed Apr. 7, 2009 Notice of Allowance dated Apr. 1, 2011.
U.S. Appl. No. 12/617,981, filed Nov. 13, 2009 Final Office Action dated Aug. 2, 2012.
U.S. Appl. No. 12/617,981, filed Nov. 13, 2009 Advisory Action dated Sep. 15, 2011.
U.S. Appl. No. 12/617,981, filed Nov. 13, 2009 Final Office Action dated Jun. 21, 2011.
U.S. Appl. No. 12/617,981, filed Nov. 13, 2009 Non-Final Office Action dated Dec. 21, 2011.
U.S. Appl. No. 12/617,981, filed Nov. 13, 2009 Non-Final Office Action dated Jan. 5, 2011.
U.S. Appl. No. 12/796,133, filed Jun. 8, 2010 Non-Final Office Action dated Feb. 17, 2011.
U.S. Appl. No. 12/796,133, filed Jun. 8, 2010 Notice of Allowance dated Jun. 9, 2011.
U.S. Appl. No. 12/917,323, filed Nov. 1, 2010 Final Office Action dated Jan. 29, 2013.
U.S. Appl. No. 12/917,323, filed Nov. 1, 2010 Non-Final Office Action dated Aug. 15, 2012.
U.S. Appl. No. 13/113,834, filed May 23, 2011 Final Office Action dated Nov. 23, 2012.
U.S. Appl. No. 13/113,834, filed May 23, 2011 Non-Final Office Action dated Jul. 17, 2012.
U.S. Appl. No. 13/159,230, filed Jun. 13, 2011 Notice of Allowance dated Aug. 1, 2012.
U.S. Appl. No. 13/250,909, filed Sep. 30, 2011 Notice of Allowance dated Aug. 6, 2012.
U.S. Appl. No. 13/438,586, filed Apr. 3, 2012 Non-Final Office Action dated Sep. 19, 2012.
U.S. Appl. No. 29/239,163, filed Sep. 27, 2005 entitled Injectable Power Port, listing Eddie K. Burnside as inventor.
U.S. Appl. No. 29/247,954, filed Jul. 21, 2006 entitled Injectable Power Port, listing Eddie K. Burnside as inventor.
U.S. Appl. No. 29/247,954, filed Jul. 21, 2006 Non-Final Office Action dated Apr. 6, 2007.
U.S. Appl. No. 29/247,954, filed Jul. 21, 2006 Notice of Allowability dated Jul. 30, 2007.
U.S. Appl. No. 29/284,454, filed Sep. 7, 2007 titled Implantable Port Device, listing John A. Zawacki and Annmarie Boswell as inventors, in which a Continued Prosecution Application was filed on Jan. 30, 2008.
U.S. Appl. No. 29/284,456, filed Sep. 7, 2007, titled Implantable Port Device, listing John A. Zawacki and Annemarie Boswell as inventors.
U.S. Appl. No. 29/382,235, filed Dec. 30, 2010 Non-Final Office Action dated Oct. 3, 2012.
U.S. Appl. No. 29/382,246, filed Dec. 30, 2010 Notice of Allowance dated Oct. 3, 2012.
U.S. Appl. No. 95/002,089, filed Aug. 20, 2012 Office Action in and Order Granting/Denying Request for Inter Partes Reexamination dated Nov. 7, 2012.
U.S. Appl. No. 95/002,090, filed Aug. 20, 2012 Office Action in and Order Granting/Denying Request for Inter Partes Reexamination dated Nov. 7, 2012.
U.S. Appl. No. 95/002,092, filed Aug. 20, 2012 Office Action in and Order Granting/Denying Request for Inter Partes Reexamination dated Nov. 13, 2012.
Vergara, et al., “Adverse Reactions to Contrast Medica in CT: Effects of Temperature and Ionic Property.” Radiology, vol. 199, No. 2, May 1996.
Vogelzang, Robert L., “Power Injection Through Central Venous Catheters: Physiological and Hemodynamic Considerations.” The McGaw Medical Center of Northwestern University, Feinberg School of Medicine. Jun. 23, 2004.
Wells, S. “Venous Access in Oncology and Haematology Patients: Part One.” Nursing Standard, vol. 22, No. 52, pp. 39-46, Sep. 3, 2008.
Wikipedia, “Port Catheter”, Dec. 15, 2011.
Williamson, et al., “Assessing the Adequacy of Peripherally Inserted Central Catheters for Power Injection of Intravenous Contrast Agents for CT.” Journal of Computer Assisted Tomography, vol. 6, No. 6, pp. 932-937, 2001.
Allergan, Inc. Lap-Band® System Fact Sheet. © 2007.
AngioDynamics, Smart Port Guidelines for Health Care Providers, 1996.
B. Braun, Easypump Product Page, accessed May 11, 2011.
B. Braun, Port Catheter Systems Product Page, accessed May 11, 2011.
Bard Access Systems Mar. 21, 1995 Product Release to Market form for “M.R.I. Port with 8 Fr. ChronoFlexÒ Catheter”, “M.R.I. Port with 8Fr. ChronoFlex Catheter with Intro-Eze™”, “M.R.I. Port with 8. Fr ChronoFlex Catheter and Peel Apart”, “M.R.I. Port with 8Fr. ChronoFlex Catheter Demo Kit”. Drawings included.
Bard Access Systems, BardPort and X-Port Implanted Ports Brochure, © 2007.
Bard Access Systems, BardPort, SlimPort and X-Port Instructions for Use, May 2003.
Bard Access Systems, BardPort™ Implanted Ports Patient Information, Feb. 1993.
Bard Access Systems, Ports Brochure, © 2003.
Bard Access Systems, Titanium Dome Implantable Port, http://www.bardacess.com, last accessed Jan. 10, 2012.
Bard Healthcare Leaflet (2001).
Baxter Guidelines on Port Maintainence (Jun. 2003).
Baxter Healthport® Focus (Oct. 1999).
Baxter Healthport® Venous Systems (Oct. 2002).
Baxter Patient Information, Healthport® System (May 1999).
Baxter Therapy Systems, Baxter Healthport® Jan. 1999.
Biffi, R. et al. “Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients.” Annals of Oncology 15:296-300, 2004.
Biffi, R., et al. “Best Choice of Central Venous Insertion Site for the Prevention of Catheter-Related Complications in Adult Patients Who Need Cancer Therapy: A Randomized Trial.” Annals of Oncology, Jan. 29, 2009.
Biffi, Roberto, et al. “A Randomized, Prospective Trial of Central Venous Ports Connected to Standard Open-Ended or Groshong Catheters in Adult Oncology Patients.” American Cancer Society, vol. 92, No. 5, pp. 1204-1212, Sep. 1, 2001.
BioEnterics Corporation, Lap-Band® “Adjustable Gastric Banding System” Product Brochure Rev. G, Nov. 2000.
Braun Product Catalog (Aug. 2005).
Cardiovascular and Interventional Radiology, Review Article, “Central Venous Access Catheters: Radiological Management of Complications,” by U.K. Teichgraber, B. Gebauer, T. Benter, H.J. Wagner, published online Jul. 31, 2003.
Carlson et al., “Safety Considerations in the Power Injection of Contrast Media Via Central Venous Catheters during Computed Tomographic Examinations,” Investigative Radiology, (May 1992) 27: 337-340.
Clinical Plastic Products, “Oncology Jet Port Plus Catheter Systems” Instructions for Use, 2011.
CN 200980153471.3 filed Jun. 30, 2011 First Office Action dated Dec. 25, 2012.
Cook Vital-Port® Product Catalog (2000).
Costa, Nancy, “More Than Skin Deep: An Overview of Iodinated Contrast Media..” Journal for the Association for Vascular Access, vol. 8, No. 4, 2003.
Costa, Nancy, “Understanding Contrast Media.” Journal of Infusion Nursing, vol. 27, No. 5, Sep./Oct. 2004.
Coyle, Douglas et al, Power Injection of Contrast Media via Peripherally Inserted Central Catheters for CT, J Vasc Interv Radiol, pp. 809-814, vol. 15, 2004.
Deltec Port Systems (Feb. and Apr. 1996).
Department of Health and Human Services, C-Port 510(k) FDA Clearance, Jun. 5, 2003.
EP 06751411 filed Apr. 25, 2006 Decision Revoking the European Patent dated Aug. 1, 2012.
EP 06751411 filed Apr. 25, 2006 Office Action dated Aug. 10, 2009.
EP 06751411 filed Apr. 25, 2006 Office Action dated Sep. 2, 2008.
EP 06751411 filed Apr. 25, 2006 Opposition by Aesculap AG dated Oct. 5, 2011.
EP 06751411 filed Apr. 25, 2006 Opposition by Fresenius Kabi Deutschland GmbH dated Oct. 11, 2011.
EP 06751411 filed Apr. 25, 2006 Opposition by pfm medical ag dated Oct. 12, 2011.
EP 06845998 filed Dec. 21, 2006 Office Action dated Mar. 10, 2011.
EP 06845998 filed Dec. 21, 2006 Supplementary Search Report dated Jul. 22, 2010.
EP 06845998.1 filed Dec. 21, 2006 Examination Report dated Nov. 7, 2012.
EP 10762377.9 filed Oct. 5, 2011 European Search Report dated Aug. 3, 2012.
EP 99964086 filed Dec. 3, 1999 Office Action dated Dec. 15, 2005.
EP 99964086 filed Dec. 3, 1999 Office Action dated Mar. 1, 2005.
EP 99964086 filed Dec. 3, 1999 Office Action dated Mar. 30, 2005.
Extravasation of Radiologic Contrast, PA-PSRS Patient Safety Advisory, vol. 1 No. 3, Sep. 2004.
Extreme Access™ Bard Access Systems, Inc. Product Brochure, 2003.
Fallscheer, et al., “Injury to the Upper Extremity Cuased by Extravasation of Contrast Medium: A True Emergency.” Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, vol. 41, pp. 26-32, 2007.
Fresenius Brochure on Intraport 1, Intraport II, and Bioport (Nov. 1998).
Gebauer, B. et al., “Contrast Media Power Injection Using Central Venous Port Catheters—Results of an In-Vitro Study,” Experimental Radiology 2005: 177: 1417-1423.
Hou, Shaw-Min et al. “Comparisons of Outcomes and Survivals for Two Central Venous Access Port Systems.” Journal of Surgical Oncology, 91:61-66, 2005.
Inamed Health, BioEntericse® Lap-Band® “Adjustable Gastric Banding System” Product Brochure, Dec. 2003.
Johnson, Kathleen A., “Power Injectable Portal Systems.” Journal of Radiology Nursing, vol. 28, Issue 1, Mar. 2009.
JP 2007-558331 filed Mar. 6, 2006 Office Action dated Jan. 22, 2013.
JP 2007-558331 filed Mar. 6, 2006 Office Action dated May 17, 2011.
JP 2008-509056 filed Apr. 25, 2006 Office Action dated Apr. 4, 2012.
JP 2008-509056 filed Apr. 25, 2006 Office Action dated Jun. 7, 2011.
Kaste et al., “Safe use of power injectors with central and peripheral venous access devices for pediatric CT,” Pediatr Radiol (1996) 26: 499-501.
L-Cath® for Ports, Luther Medical Products, Inc., Tustin, California, 2 pages, 1994.
LaMaitre Vascular “Port Implantations: using the OptiLock Implantable Port,” product information, available at http://www.lemaitre. com/specs.pop.asp, last accessed Apr. 2003, 14 pages.
Lap-Band AP™ “System with Adjustable Gastric Banding system with Omniform TN Design,” Product Brochure, Jul. 2007, 16 pages.
Lap-Band® System Access Port Fill Guide I, “9.75/10.0 cm Lap-Band System vs. 11 cm Lap-Band System: For Product Manufactured Prior to Jul. 2001” BioEnterics Corporation.
Leslie et al., “A New Simple Power Injector,” Am J Roentgenol 128: 381-384, Mar. 1977.
MedComp “PortCT Technology”, display at SIR Conference (Mar. 2006), Toronto, Canada.
Medtronic IsoMed® Constant-Flow Infusion System: Clinical Reference Guide for Hepatic Arterial Infusion Therapy, Revised Sep. 2000.
Navilyst Medical, Implantable Ports with PASV® Valve Technology, Product Overview,<<http://www.navilystmedical.com/Products/index.cfm/9>> last accessed Jun. 4, 2012.
Nucleus Cochlear Implant Systems; User Manual for the ESPrit 3G speech processor and accessories, Issue 2, Dec. 2001 http://www.cochlearamericas.com/PDFs/UserManualSprint.pdf.
Nucleus Cochlear Implant Systems; User Manual for the ESPrit and ESPrit 22 speech processor and accessories, Issue 3, Apr. 2000.
Oct. 22, 2009 Declaration of Kelly Christian, Director of Product Development at BARD Access Systems, Inc, in support of and depicting a product on the market by Quinton Company approximately ten years prior to Oct. 22, 2009, 1 page.
PCT/US11/37038 filed May 18, 2011 Written Opinion and Search Report dated Aug. 30, 2011.
PCT/US1999/028695 filed Dec. 3, 1999 International Preliminary Examination Report dated Apr. 21, 2001.
PCT/US1999/028695 filed Dec. 3, 1999 Search Report dated Apr. 11, 2000.
PCT/US2006/008022 filed Mar. 6, 2006 International Preliminary Report on Patentability dated Sep. 12, 2007.
PCT/US2006/008022 filed Mar. 6, 2006 Search Report dated Jul. 5, 2006.
PCT/US2006/008022 filed Mar. 6, 2006 Written Opinion dated Apr. 9, 2007.
PCT/US2006/008022 filed Mar. 6, 2006 Written Opinion dated Jul. 5, 2006.
PCT/US2006/015695 filed Apr. 25, 2006 Partial Search Report dated Sep. 29, 2006.
PCT/US2006/015695 filed Apr. 25, 2006 Search Report dated Jan. 11, 2007.
PCT/US2006/015695 filed Apr. 25, 2006 Written Opinion dated Jan. 11, 2007.
PCT/US2006/016056 filed Apr. 27, 2006 International Preliminary Report on Patentability dated Oct. 30, 2007.
PCT/US2006/016056 filed Apr. 27, 2006 Search Report dated Sep. 20, 2006.
PCT/US2006/016056 filed Apr. 27, 2006 Written Opinion dated Oct. 27, 2007.
PCT/US2006/016056 filed Apr. 27, 2006 Written Opinion dated Sep. 20, 2006.
PCT/US2006/049007 filed Dec. 21, 2006 International Preliminary Report on Patentability dated Jul. 1, 2008.
PCT/US2006/049007 filed Dec. 21, 2006 Search Report dated Oct. 1, 2007.
PCT/US2006/049007 filed Dec. 21, 2006 Written Opinion dated Oct. 1, 2007.
PCT/US2007/006776 filed Mar. 19, 2007 International Preliminary Report on Patentability dated Jan. 2, 2009.
PCT/US2007/006776 filed Mar. 19, 2007 Search Report, dated Dec. 18, 2007.
PCT/US2007/006776 filed Mar. 19, 2007 Written opinion, dated Dec. 18, 2007.
PCT/US2007/011015 dated May 7, 2007 Written Opinion dated Jun. 10, 2008.
PCT/US2007/011015 filed May 7, 2007 International Preliminary Report on Patentability dated Oct. 29, 2008.
PCT/US2007/011015 filed May 7, 2007 Search Report dated Jun. 10, 2008.
PCT/US2007/011456 filed May 11, 2007 Search Report dated Aug. 28, 2008.
PCT/US2007/011456 filed May 11, 2007 Written Opinion dated Aug. 28, 2008.
PCT/US2008/010520 dated Sep. 8, 2008 Search Report dated Feb. 24, 2009.
PCT/US2008/010520 filed Sep. 8, 2008 Written Opinion dated Feb. 24, 2009.
PCT/US2008/067679 filed Jun. 20, 2008 Search Report dated Sep. 30, 2008.
PCT/US2008/067679 filed Jun. 20, 2008 Written Opinion mailed on Sep. 30, 2008.
PCT/US2008/070330 filed Jul. 17, 2008 Search Report dated Dec. 1, 2008.
PCT/US2008/070330 filed Jul. 17, 2008 Written Opinion dated Dec. 1, 2008.
PCT/US2008/070345 filed Jul. 17, 2008 Search Report mailed on Dec. 1, 2008.
PCT/US2008/070345 filed Jul. 17, 2008 Written Opinion dated Dec. 1, 2008.
PCT/US2008/078976 filed Apr. 2, 2009 Search Report and Written Opinion dated Apr. 3, 2009.
PCT/US2009/035088 filed Feb. 25, 2009 International Search Report dated May 19, 2009.
PCT/US2009/035088 filed Feb. 25, 2009 Written Opinion dated May 19, 2009.
PCT/US2009/062854 filed Oct. 30, 2009 International Preliminary Report on Patentability dated May 5, 2011.
PCT/US2009/062854 filed Oct. 30, 2009 International Search Report dated Dec. 10, 2009.
PCT/US2009/062854 filed Oct. 30, 2009 Search Report dated Dec. 23, 2009.
PCT/US2009/062854 filed Oct. 30, 2009 Written Opinion dated Dec. 10, 2009.
PCT/US2009/062854 filed Oct. 30, 2009 Written Opinion dated Dec. 23, 2009.
PCT/US2010/030256 filed Apr. 7, 2010 Search Report dated Jun. 4, 2010.
PCT/US2010/030256 filed Apr. 7, 2010 Written Opinion dated Jun. 4, 2010.
PCT/US2010/054994 filed Nov. 1, 2010 Search Report dated Jan. 10, 2011.
PCT/US2010/054994 filed Nov. 1, 2010 Written Opinion dated Jan. 10, 2011.
PCT/US2011/037038 filed May 18, 2011 International Preliminary Report on Patentability dated Nov. 29, 2012.
PCT/US2011/037038 filed May 18, 2011 International Search Report and Written Opinion dated Aug. 30, 2011.
Port-A-Cath® P.A.S. Port® Systems by Deltec, Product Specifications, 1999.
Port-A-Cath® “Implantable Epidural, Aterial and Peritonial Access Systems” Internet Product Listing. <<http://web.archive.org/web/20001119035900/www.deltec.com/cPacspl.htm.>> last accessed Jun. 4, 2012.
Port-A-Cath® “Many Port-A-Cath® System Choices” Product Brochure. ©1996 SIMS Deltec, Inc.
Port-A-Cath® & Port-A-Cath® II Dual-Iumen Implantable Venous Access Systems Product Specifications, 2005.
Port-A-Cath® and P.A.S. Port® Power P.A.C. Information Sheet, 2006.
Rappolt, Richard T., et al. “Radiopaque Codification and X-ray Identification of Ingested Drugs.” Ingestive Radiology, May-Jun. 1966.
Request for Inter partes Reexamination of U.S. Pat. No. 7,785,302, filed Aug. 20, 2012.
Request for Inter partes Reexamination of U.S. Pat. No. 7,947,022, filed Aug. 20, 2012.
Request for Inter partes Reexamination of U.S. Pat. No. 7,959,615, filed Aug. 20, 2012.
Salis et al., “Maximal flow rates possible during power injection through currently available PICCs: An in-vitro study,” J Vasc Interv Radiol 2004; 15:275-281.
Sandstede, Joern, “Pediatric CT,” available online at www.multislice-ct.com, MultiSLICE-CT.com, version 02, May 2, 2003.
Sanelli, et al., “Safety and Feasibility of Using a Central Venous Catheter for Rapid Contrast Injection Rates.” American Journal of Radiology, vol. 183, pp. 1829-1834, Dec. 2004.
Shah, Tilak M., “Radiopaque Polymer Formulations for Medical Devices.” Medical Device and Diagnostic Industry, Mar. 2000.
Smith Medical, Port-A-Cath® “Single-Iumen Implantable Vascular Access Systems” Product Specifications, 2004.
Smith, Lisa Hartkoph, “Implanted Ports, Computed Tomography, Power Injectors, and Catheter Rupture.” Clinical Journal of Oncology Nursing, vol. 12 , No. 5. Oct. 2008.
Smiths Medical, “Smiths Medical Launches Implantable Ports for Easy Viewing Under CT Scans” Press Release, Jan 5, 2011.
Soloman, et al., “CIN Strategies: Anticipate, Manage, Prevent.” Supplement to Imaging Economics, May 2007.
Statement of Prof. Dr. med. Karl R. Aigner, Oct. 11, 2011.
Steinbach, Barbara G. , Hardt, N. Sisson, Abbitt, Patricia L., Lanier, Linda, Caffee, H. Hollis, “Breast Implants, Common Complications, and Concurrent Breast Disease.” RadioGraphics, vol. 13, No. 1, pp. 95-118, 1993.
Sullivan et al. “Radiopaque Markers on Mammary Implants.” American Journal of Roentgenology 153(2):428, Aug. 1989.
U.S. Food and Drug Administration, “Guidance for Institutional Review Boards and Clinical Investigators 1998 Update: Medical Devices.” Version Sep. 10, 2008.
U.S. Appl. No. 60/658,518, filed Mar. 4, 2005, publicly accessible Oct. 5, 2006.
Urquiola, Javier, et al., “Using Lead Foil as a Radiopaque Marker for Computerized Tomography Imaging When Implant Treatment Planning.” The Journal of Prosthetic Dentistry, 1997.
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Office Action dated Aug. 28, 2007.
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Advisory Action dated Jan. 23, 2007.
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Non-Final Office Action dated Feb. 13, 2006.
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Non-Final Office Action dated May 20, 2009.
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Non-final Office Action mailed Mar. 20, 2008.
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Office Action dated Feb. 28, 2007.
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Office Action dated Jul. 28, 2006.
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Office Action mailed Sep. 30, 2008.
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Response to Non-Final Office Action dated May 12, 2006.
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Response to Office Action dated Dec. 28, 2006.
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Response to Office Action dated Jun. 20, 2008.
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Response to Office Action dated Mar. 30, 2009.
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Response to Office Action dated May 28, 2007.
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Response to Office Action dated Nov. 28, 2006.
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Response to Office Action dated Oct. 31, 2007.
U.S. Appl. No. 10/374,000, filed Feb. 25, 2003 Response to Office Action dated Sep. 21, 2009.
U.S. Appl. No. 11/320,223, filed Dec. 28, 2005 Advisory Action dated Dec. 1, 2011.
U.S. Appl. No. 11/320,223, filed Dec. 28, 2005 Notice of Allowance dated Jan. 6, 2012.
U.S. Appl. No. 11/320,223, filed Dec. 28, 2005 Final Office Action dated Aug. 3, 2011.
U.S. Appl. No. 11/320,223, filed Dec. 28, 2005 Final Office Action dated Jun. 19, 2009.
U.S. Appl. No. 11/320,223, filed Dec. 28, 2005 Final Office Action dated Jun. 22, 2010.
U.S. Appl. No. 11/320,223, filed Dec. 28, 2005 Non-Final Office Action dated Feb. 13, 2008.
U.S. Appl. No. 11/320,223, filed Dec. 28, 2005 Non-Final Office Action dated Jan. 21, 2010.
U.S. Appl. No. 11/320,223, filed Dec. 28, 2005 Non-Final Office Action dated Mar. 16, 2011.
U.S. Appl. No. 11/320,223, filed Dec. 28, 2005 Non-Final Office Action dated Sep. 18, 2008.
U.S. Appl. No. 11/368,954, filed Mar. 6, 2006 Non-Final Office Action dated Jul. 21, 2009.
U.S. Appl. No. 11/368,954, filed Mar. 6, 2006 Notice of Allowance dated Jun. 24, 2010.
U.S. Appl. No. 11/368,954, filed Mar. 6, 2006 Final Office Action dated Jan. 27, 2010.
U.S. Appl. No. 11/368,954, filed Mar. 6, 2006 Supplemental Non-final Office Action mailed Oct. 2, 2009.
U.S. Appl. No. 11/380,124, filed Apr. 25, 2006 Final Office Action dated Aug. 13, 2010.
U.S. Appl. No. 11/380,124, filed Apr. 25, 2006 Final Office Action dated Oct. 20, 2011.
U.S. Appl. No. 11/380,124, filed Apr. 25, 2006 Final Office Action dated Sep. 21, 2009.
U.S. Appl. No. 11/380,124, filed Apr. 25, 2006 Non-Final Office Action dated Apr. 26, 2010.
U.S. Appl. No. 11/380,124, filed Apr. 25, 2006 Non-Final Office Action dated Apr. 7, 2011.
U.S. Appl. No. 11/380,124, filed Apr. 25, 2006 Non-Final Office Action dated Jan. 16, 2009.
U.S. Appl. No. 11/380,124, filed Apr. 25, 2006 Non-Final Office Action dated Oct. 28, 2010.
U.S. Appl. No. 11/380,621, filed Apr. 27, 2006 Final Office Action dated Jan. 14, 2010.
U.S. Appl. No. 11/380,621, filed Apr. 27, 2006 Final Office Action dated Jan. 23, 2009.
U.S. Appl. No. 11/380,621, filed Apr. 27, 2006 Final Office Action dated Mar. 8, 2011.
U.S. Appl. No. 11/380,621, filed Apr. 27, 2006 Non-Final Office Action dated Jul. 1, 2009.
U.S. Appl. No. 11/380,621, filed Apr. 27, 2006 Non-Final Office Action dated Jun. 6, 2008.
U.S. Appl. No. 11/725,287, filed Mar. 19, 2007 Non-final Office Action issued on Dec. 3, 2008.
U.S. Appl. No. 11/725,287, filed Mar. 19, 2007 Non-final Office Action issued on Jun. 12, 2009.
U.S. Appl. No. 11/725,287, filed Mar. 19, 2007 Non-final Office Action issued on Mar. 29, 2010.
U.S. Appl. No. 11/937,302, filed Nov. 8, 2007 Final Office Action dated Nov. 8, 2012.
U.S. Appl. No. 11/937,302, filed Nov. 8, 2007 Final Office Action dated Oct. 13, 2011.
U.S. Appl. No. 11/937,302, filed Nov. 8, 2007 Non-Final Office Action dated Jun. 18, 2012.
U.S. Appl. No. 11/937,302, filed Nov. 8, 2007 Final Office Action dated Feb. 11, 2011.
U.S. Appl. No. 11/937,302, filed Nov. 8, 2007 Non-Final Office Action dated Apr. 15, 2011.
U.S. Appl. No. 11/937,302, filed Nov. 8, 2007 Non-Final Office Action dated Sep. 13, 2010.
U.S. Appl. No. 12/023,280, filed Jan. 31, 2008 Final Office Action dated Mar. 9, 2010.
U.S. Appl. No. 12/023,280, filed Jan. 31, 2008 Non-Final Office Action dated Dec. 13, 2010.
U.S. Appl. No. 12/023,280, filed Jan. 31, 2008 Non-Final Office Action dated Jul. 23, 2009.
U.S. Appl. No. 12/023,280, filed Jan. 31, 2008 Non-Final Office Action dated Oct. 5, 2009.
U.S. Appl. No. 12/023,280, filed Jan. 31, 2008 Notice of Allowance dated Mar. 28, 2011.
U.S. Appl. No. 12/143,377, filed Jun. 20, 2008 Final Office Action mailed Oct. 19, 2009.
U.S. Appl. No. 12/143,377, filed Jun. 20, 2008 Non-final Office Action mailed Apr. 27, 2009.
U.S. Appl. No. 12/175,182, filed Jul. 17, 2008 Non-final Office Action mailed Sep. 3, 2009.
CN 200980153471.3 filed Jun. 30, 2011 Second Office Action dated Sep. 18, 2013.
CN 201080020088.3 filed Nov. 7, 2011 Second Office Action dated Nov. 21, 2013.
CN 201080051911.7 filed May 16, 2012 First Office Action dated Dec. 27, 2013.
EP 06751411 filed Apr. 25, 2006 Decision of the Technical Board of Appeal dated Jul. 24, 2013.
EP 06845998.1 filed Dec. 21, 2006 Examination Report dated Feb. 6, 2014.
EP 10183382.0 filed Apr. 25, 2006 Intent to Grant dated Mar. 7, 2014.
EP 11784194.0 filed Nov. 29, 2012 extended European search report dated Feb. 21, 2014.
EP 13158343.7 filed Mar. 8, 2013 Examination Report dated Feb. 4, 2014.
JP 2007-558331 filed Mar. 6, 2006 Office Action dated Aug. 20, 2013.
JP 2012-156976 filed Jul. 12, 2012 Notice of Reasons for Refusal dated Aug. 27, 2013.
MX/a/2011/004499 filed Apr. 28, 2011 First Office Action dated Jul. 25, 2013.
PCT/US2013/056019 filed Aug. 21, 2013 International Search Report and Written Opinion dated Feb. 28, 2014.
U.S. Appl. No. 13/438,586, filed Apr. 3, 2012 Notice of Allowance dated Sep. 16, 2013.
U.S. Appl. No. 13/524,712, filed Jun. 15, 2012 Non-Final Office Action dated Oct. 22, 2013.
U.S. Appl. No. 13/776,517, filed Feb. 25, 2013 Non-Final Office Action dated Nov. 15, 2013.
U.S. Appl. No. 13/853,956, filed Mar. 29, 2013 Non-Final Office Action dated Dec. 3, 2013.
U.S. Appl. No. 13/853,961, filed Mar. 29, 2013 Non-Final Office Action dated Dec. 3, 2013.
CN 200980153471.3 filed Jun. 30, 2011 Third Office Action dated May 28, 2014.
EP 10 831 973.2 filed May 30, 2012 Extended European Search Report dated Jul. 4, 2014.
EP 10183394.5 filed Apr. 25, 2006 Opposition by Smiths Medical ASD, Inc. dated Apr. 25, 2014.
JP 2012-156976 filed Jul. 12, 2012 Notice of Reasons for Refusal dated Apr. 8, 2014.
JP 2012-504826 filed Oct. 6, 2011 First Office Action dated Mar. 4, 2014.
U.S. Appl. No. 12/419,854, filed Apr. 7, 2009 Notice of Allowance dated Apr. 7, 2014.
U.S. Appl. No. 13/110,734, filed May 18, 2011 Non-Final Office Action dated Jul. 7, 2014.
U.S. Appl. No. 13/524,712, filed Jun. 15, 2012 Advisory Action dated May 7, 2014.
U.S. Appl. No. 13/524,712, filed Jun. 15, 2012 Final Office Action dated Mar. 3, 2014.
U.S. Appl. No. 13/776,517, filed Feb. 25, 2013 Final Office Action dated Jun. 30, 2014.
U.S. Appl. No. 13/776,517, filed Feb. 25, 2013 Non-Final Office Action dated Feb. 27, 2014.
B. Braun, Access Port Systems, Celsite® Product Information, 19 pages, Nov. 2005.
Bard Access Systems, Devices for Small Patients, 4 pages, Jul. 1992.
Bard Access Systems, Family of PICCs, 1 page, Mar. 10, 2006.
Bard Access Systems, M.R.I. Dual Port with Septum-Finder Ridge IFU, 2 pages, © 1993.
Bard Access Systems, PowerPort Implanted Port with Open-Ended Catheter Instructions for Use, 8 pages, Dec. 2006.
Bard Access Systems, PowerPort Information for the Patient, 5 pages, © 2006.
Bard Access Systems, PowerPort Product Brochure, 8 pages, © 2009.
CN 201080051911.7 filed May 16, 2012 Third Office Action dated Jan. 30, 2015.
Department of Health and Human Services, PowerPort 510(k) FDA Clearance, Jan. 25, 2007.
EP 06751664.1 filed Apr. 27, 2006 Second Examination Report dated Dec. 17, 2014.
JP 2013-511339 filed Nov. 16, 2012 First Office Action dated Feb. 19, 2015.
MX/a/2011/004499 filed Apr. 28, 2011 Third Office Action dated Jan. 21, 2015.
U.S. Appl. No. 12/917,323, filed Nov. 1, 2010 Notice of Allowance dated Jan. 21, 2015.
U.S. Appl. No. 13/853,956, filed Mar. 29, 2013 Final Office Action dated Feb. 20, 2015.
U.S. Appl. No. 13/853,961, filed Mar. 29, 2013 Final Office Action dated Feb. 20, 2015.
U.S. Appl. No. 14/171,364, filed Feb. 3, 2014 Non-Final Office Action dated Feb. 12, 2015.
U.S. Appl. No. 14/455,660, filed Aug. 8, 2014 Non-Final Office Action dated Mar. 18, 2015.
Related Publications (1)
Number Date Country
20150088091 A1 Mar 2015 US
Provisional Applications (2)
Number Date Country
60864806 Nov 2006 US
61614939 Mar 2012 US
Continuation in Parts (1)
Number Date Country
Parent 11937302 Nov 2007 US
Child 13801893 US